Dichroic azo-azomethine dyes for liquid crystal compositions
By using specific azo-azomethyl dyes in the liquid crystal composition, the problem of insufficient dichromatic ratio and solubility of dichromatic dyes in the liquid crystal composition in the prior art is solved, and a high dichromatic ratio is achieved and good durability, improving the light stability and durability of the light-absorbing anisotropic element.
Patent Information
- Application Number
- CN202080011748.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-02-01
- Filing Date
- 2020-01-17
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2040-01-17
AI Technical Summary
The prior art is difficult to achieve high dichromatic ratio and high solubility in liquid crystal compositions, and has good durability and light stability, especially in light absorption anisotropic elements, where there is chromatographic unevenness and light resistance. The problem of sexual inadequacy.
A specific azo-azomethyl dye has been developed, and its compound structure includes specific alkyl, aryl and halogenated groups. By combining with liquid crystal materials, a dye mixture with high dichromatic ratio and good solubility is formed. It is used for light absorption anisotropic elements, improving the stability and light resistance of dyes.
High dichromaticity ratio and high solubility in liquid crystal compositions are achieved, durability and light stability of dyes are enhanced, and the performance of light absorption anisotropic elements is improved, especially long-life performance under high power conditions.
Smart Images

Figure CN113366063B_ABST
Abstract
Description
[0001] The present invention relates to an azo-azomethine dye, a dichroic dye mixture containing the azo-azomethine dye, a liquid crystal composition containing a liquid crystal material and the azo-azomethine dye, and a method for preparing the azo-azomethine dye. In addition, the present invention relates to a light-absorbing anisotropic element containing the azo-azomethine dye. The azo-azomethine dye is suitable as a part of the light-absorbing anisotropic element in a switchable optical device, for example, as a polymer dispersed liquid crystal system, a reverse polymer dispersed liquid crystal system, a polymer network liquid crystal system, a light shutter for a smart window or decorative element, a transmissive display or a reflective display, or as a part of the light-absorbing anisotropic element in an optical anisotropic film, for example, as a stretched polymer film, a coatable polarizer, a phase difference film, an anti-counterfeiting mark or a brand protection mark. Background of the Invention
[0003] Azo compounds are of interest for many areas of application technology. It is known, for example, that chromophores based on azo compounds are suitable as dichroic dyes.
[0004] Within the meaning of the present invention, a dichroic dye is a light-absorbing compound in which the absorption properties depend on the alignment (orientation) of the compound relative to the polarization direction of the light. Dichroic dye compounds generally have an elongated shape, i.e. the compound is significantly longer in one spatial direction (longitudinal) than in the other two spatial directions.
[0005] Therefore, dichroic dyes can be used in liquid crystal mixtures for switchable optical devices.
[0006] Using such liquid crystal mixtures comprising at least one dichroic dye, the light absorption or emission (or both) of the dye can be controlled. A measure of how well the absorption can be controlled is the dichroic ratio (DR) of the dye in the liquid crystal mixture. The dichroic ratio (DR) is the absorption (A) of light polarized parallel to the orientation axis of the molecule. ll ) relative to the absorption of light polarized perpendicular to the orientation axis (A ⊥ ) ratio: DR (dichroic ratio) = A ll / A ⊥ .
[0007] Another value that expresses the degree of dichroism is the order parameter (S), which is defined as The order parameter is 1 for perfect order and 0 for a completely isotropic system.
[0008] A high dichroic ratio or order parameter allows for high contrast in absorption, which is desirable in many applications.
[0009] In order to achieve good control over light absorption, a high dichroic ratio is desired.
[0010] Additionally, it is desirable to have a high solubility of the dichroic dye in the liquid crystal mixture. The higher the solubility of the dye, the higher the optical contrast of the light control device.
[0011] In addition, it is desirable that the dyes have high photostability. Photostability allows for long lifetimes of devices in high power conditions such as sunlight, lasers, or indoor lighting.
[0012] Due to their good dichroic ratios, azo chromophores have been suggested as dyes in liquid crystal mixtures.
[0013] WO 2011 / 157614 A1 discloses a blue dichroic polyazo dye, a black dichroic dye composition comprising the blue dye and additionally at least one red polyazo dye, and its use in display technology. The composition comprises, for example, the following compounds:
[0014]
[0015] US 4,565,424 A relates to dichroic dyes and guest-host combinations thereof with nematic liquid crystals. Dichroic dyes are asymmetric molecules with poly(arylazo) linking groups, disubstituted arylthiazolyl substituents and naphthyl, perylene diazine or julolidine substituents. The use of these dichroic dyes with additional well-known dichroic dyes having maximum absorption between about 400-600nm in liquid crystal devices provides a display that usually alternates between neutral black and transparent states when an electric field is present or absent. An example of a suitable dye according to US 4,565,424 A is dye 1 having the following structure:
[0016]
[0017] JP 2011-046904A discloses a dichroic dye composition containing at least one liquid crystal dichroic dye of the general formula (I): Ar 1 -N=N-Ar 2 -L 1 -Ar 3 -L 2 -Ar 4 (I), for example, compound A9 having the following structure, which requires an azo-containing aldehyde to prepare:
[0018] The composition is described as having a high dichroic ratio and good orientation properties and being suitable for forming a polarizing film having a thin film thickness and a high polarization degree. The film can be used in a liquid crystal display device.
[0019] JP S61-098768 A discloses yellow to purple benzophenone for use in liquid crystal displays. Azotriazole-substituted diazo or azo-azomethine dyes. JP S60-262858 A discloses benzotriazole-substituted azo dyes.
[0020] EP 0202341 A1 discloses dichroic azo dyes having the typical features of p-substituted biphenylene-azo-1,4-naphthylene units, which are described as being suitable for use in liquid crystal displays, for example compounds of the formula:
[0021]
[0022] In H. Seki et al., Mol. Cryst. Liq. Cryst., 1981, Vol. 66, pp. 209-218, the light stability of color liquid crystal display devices using guest-host interactions was studied. Various azomethine-, diazo- and anthraquinone dyes with high dichroic ratios were put to the test, with the biphenyl mixture LIXON GR-41 (Chisso Corp.) being used as the host. An azomethine dye is mentioned in H. Seki et al.:
[0023]
[0024] US 2015 / 0218455 A1 discloses a dichroic dye mixture, for example comprising the same azo-azomethine dye as disclosed by Seki et al. and two dichroic dyes based on amino-anthraquinones. The mixture contained in the main liquid crystal composition MLC-2039 (Merck) is described as having uniform absorption of light between 420-680 nm and having good low temperature storage stability.
[0025] US 2006 / 0147652 A1 discloses dichroic dyes described as having good solubility and high dichroic ratios, such as compounds having the following structures, and dichroic compositions containing them in ZLI 1840 (Merck):
[0026]
[0027] The prior art mentioned above mainly relates to liquid crystal "guest-host" systems, for example for use in display devices. The term "host" relates to the liquid crystal material, while the term "guest" relates to agents that can be oriented by the host to produce contrasting light absorption states.
[0028] As mentioned previously, a high dichroic ratio is required to achieve good control of light absorption (or emission or both). Additionally, it is desirable to have high compatibility, such as high solubility and good durability of the dichroic dye in the liquid crystal mixture.
[0029] To provide high solubility, dyes with long alkyl groups or optionally substituted phenylcyclohexyl groups are preferred, as such groups positively affect solubility. To provide a sufficiently high dichroic ratio, the dichroic dye is generally in an elongated shape, with substituents similar to the liquid crystal material, which also includes an elongated shape. There is a continuing need for dichroic dyes to meet the requirements of high solubility and high dichroic ratio.
[0030] It was therefore an object of the present invention to provide readily available dichroic dyes for use in liquid crystal compositions which have high compatibility, for example high solubility in the liquid crystal mixture and good durability, such as high light fastness, and at the same time have a high dichroic ratio. SUMMARY OF THE INVENTION
[0032] It has now been found that certain azo-azomethine dyes feature a high dichroic ratio and also high compatibility, for example high solubility in liquid-crystalline mixtures and good durability.
[0033] Therefore, the present invention relates in a first aspect to compounds of formula (A) or (B):
[0034]
[0035]
[0036] in
[0037] Ar 1 ,Ar 5 and Ar 10 are independently selected from The residues of
[0038] Ar 2 ,Ar 3 ,Ar 6 ,Ar 7 ,Ar 8 and Ar 9 Independently and at each occurrence, selected from
[0039] Ar 4 yes C2-C 10 Heteroaryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12Alkylthio, OH, halogen, C1-C4 haloalkyl, NR 12 R 13 、CO2R 14 , COR 15 、SO2R 16 , NO2 or CN substituted C2-C 10 heteroaryl residues;
[0040] X is C1-C6 haloalkyl, halogen, CN, COOR 17 ,CONR 18 R 19 、SO2R 20 or a heteroaryl group selected from
[0041] Y is H, C1-C 12 Alkyl, substituted by OH or NH2 and / or NR 23 , O or S interval C1-C 12 Alkyl, C1-C 12 Halogenated alkyl, C7-C 12 Aralkyl, NR 24 R 25 , halogen, CN, OH, C1-C 12 Alkoxy, O-interrupted C2-C 12 Alkoxy, C1-C 12 Alkylthio, COOR 26 , C6-C 12 Aryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12 Alkylthio, CN, halogen, OH or NR 27 R 28 Substituted C6-C 12 Aryl, C2-C 10 Heteroaryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12 Alkylthio, OH, halogen, CN or NR 29 R 30 Substituted C2-C 10 Heteroaryl, C3-C 18 Cycloalkyl or C1-C 12 Haloalkyl, halogen, CN, OH, C1-C 12 Alkoxy, C1-C 12 Alkylthio or NR 31 R 32 C3-C substituted and / or interrupted by one or more O18 Cycloalkyl;
[0042] Or Y and an adjacent H together form a group or a 5-7 membered heterocyclic ring containing one or two Qs,
[0043] Q is NR 33 , O or S;
[0044] The group or the heterocycle is unsubstituted or substituted by C1-C4 alkyl;
[0045] R 1 It is C1-C 12 Alkyl, C1-C 12 Haloalkyl, halogen, CN, C1-C 12 Alkoxy or O-interrupted C2-C 12 Alkoxy;
[0046] R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 21 and R 22 independently of one another and at each occurrence selected from H, halogen, OCF3, NO2, CN, formyl, COOR 34 , COR 35 , SO2R 36 ,CONR 37 R 38 , C1-C 12 Alkyl, C1-C substituted by halogen or CN 12 Alkyl, C1-C 12 Alkoxy, O-interrupted C2-C 12 Alkoxy, C3-C 12 Cycloalkyl, C3-C4-substituted by halogen or CN and / or interrupted by one or more O 12 Cycloalkyl, phenyl or phenyl substituted by halogen, CN, C1-C8 alkyl or C1-C8 haloalkyl;
[0047] or R 2 and R 3 or R 6 and R 7 Together they are C3-C4 alkylene or form a benzo-fused ring, wherein the alkylene or benzo-fused ring is unsubstituted or substituted by C1-C4 alkyl, CN, C1-C4 alkoxy, NO2, halogen or SO2R 39 replace;
[0048] or R21 and R 22 Together, they are C3-C4 alkylene, which is unsubstituted or substituted with C1-C4 alkyl, CN, C1-C4 alkoxy, NO2, halogen or SO2R 40 replace;
[0049] R 8 and R 9 independently of one another and at each occurrence are selected from C1-C4-alkyl, C1-C4-haloalkyl, halogen, CN or C1-C4-alkoxy;
[0050] R 10 Select from C1-C at each occurrence 12 Alkyl, C1-C4 haloalkyl, C1-C 12 Alkoxy, OH, halogen or CN;
[0051] R 11 is C1-C4 alkyl at each occurrence,
[0052] R 14 , R 15 , R 16 , R 17 , R 20 , R 26 , R 34 , R 35 , R 36 , R 39 and R 40 Independently of each other are C1-C 12 Alkyl, C1-C substituted by CN or OH 12 Alkyl, C1-C 12 Halogenated alkyl, C3-C 18 Cycloalkyl, C1-C 12 C3-C4-substituted with halogenated alkyl, CN, OH or halogen and / or interrupted by one or more O 12 Cycloalkyl, C6-C 12 Aryl, halogen, CN, OH, C1-C 12 Alkyl or C1-C 12 C6-C 12 Aryl, phenylene-C3-C 18 Cycloalkyl, phenylene substituted by halogen, CN or OH-C3-C 18 Cycloalkyl, C3-C 12 Cycloalkylenephenyl or C1-C 12 Alkyl, C1-C 12 C3-C substituted with halogenated alkyl, halogen, CN or OH 12 Cycloalkylenephenyl;
[0053] R 12 , R 13 , R 18 , R 19 , R 24 , R 25 , R 27 , R 28 , R 29 , R 30 , R 31 , R 32 , R 37 or R 38 Independently of each other are H, C1-C 12 Alkyl, C3-C 14 Cycloalkyl, C6-C 12 Aryl, halogen, CN, OH, C1-C 12 Alkyl or C1-C 12 C6-C 12 Aryl, phenylene-C3-C 18 Cycloalkyl, phenylene substituted by halogen, CN or OH-C3-C 18 Cycloalkyl, C3-C 12 Cycloalkylenephenyl or C1-C 12 Alkyl, C1-C 12 C3-C substituted with halogenated alkyl, halogen, CN or OH 12 Cycloalkylenephenyl;
[0054] or R 12 and R 13 , R 18 and R 19 , R 24 and R 25 , R 27 and R 28 , R 29 and R 30 , R 31 and R 32 or R 37 and R 38 Together for C2-C 12 Alkylene or replaced by O, S and / or NR 41 Interval C2-C 12 Alkylene;
[0055] R 23 , R 33 and R 41 Independently of each other are H, C1-C 12 Alkyl, C3-C 12 Cycloalkyl, phenyl or phenyl substituted by C1-C6 alkyl, F or CN;
[0056] L is a single bond or selected from C4-C 10 Heteroarylene or R 44 Substituted C4-C 10 Heteroarylene groups;
[0057] R 42 , R 43 and R 44 independently of one another and at each occurrence are selected from C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, halogen, OH, CN or COOR 45 ;
[0058] R 45 is a C1-C4 alkyl group,
[0059] m, n, p and q are independently 0 or 1,
[0060] The condition is that the sum m+n ≥ 1;
[0061] s, t, u, v, y and z are independently 0, 1 or 2;
[0062] w is 0, 1, 2, 3, or 4; and
[0063] x is 1 or 2.
[0064] In another aspect, the invention relates to a process for the preparation of a compound of formula (A) or (B) as defined herein.
[0065] In another aspect, the present invention relates to a dichroic dye mixture comprising one or more compounds of formula (A) or (B) as defined herein and, optionally, further dichroic dyes.
[0066] In another aspect, the present invention relates to a liquid crystal composition comprising a liquid crystal material and at least one compound of formula (A) or (B) as defined herein or a dichroic dye mixture as defined herein.
[0067] In another aspect, the invention relates to a light absorbing anisotropic element comprising a compound of formula (A) or (B) as defined herein or a dichroic dye mixture as defined herein or a liquid crystal composition as defined herein.
[0068] In another aspect, the invention relates to a switchable optical device comprising a compound of formula (A) or (B) as defined herein or a dichroic dye mixture as defined herein or a liquid crystal composition as defined herein.
[0069] In another aspect, the invention relates to an optically anisotropic film comprising at least one compound of formula (A) or (B) as defined herein or a dichroic dye mixture as defined herein or a liquid crystal composition as defined herein.
[0070] In another aspect, the present invention relates to the use of a compound of formula (A) or (B) as defined herein or a dichroic dye mixture as defined herein or a liquid crystal composition as defined herein in a light absorbing anisotropic element as a component of a switchable optical device or a component of an optically anisotropic film. DETAILED DESCRIPTION OF THE INVENTION
[0072] The terms alkyl, alkylene, cycloalkyl, haloalkyl, alkoxy, aryl, heteroaryl, aralkyl, halogen are known in the art and generally have the following meanings, if the groups are not further defined in the following specific embodiments:
[0073] Alkyl, such as C1-C4 alkyl, C1-C6 alkyl, C1-C8 alkyl, C1-C 12 Alkyl, C5-C 12 Alkyl, C2-C 12 Alkyl, within the given carbon atom limit, can be linear or branched, if possible. Examples are methyl (Me), ethyl (Et), n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, 2-pentyl, 3-pentyl, 2,2-dimethylpropyl, n-hexyl, 1-methylhexyl, n-heptyl, isoheptyl, 1,1,3,3-tetramethylbutyl, 1-methylheptyl, 3-methylheptyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl and the structural isomers of the above n-alkyl. Any alkyl moiety can be substituted, for example, by F, CN and / or OH, preferably F or CN.
[0074] Any alkyl, alkoxy or alkylthio moiety having more than one, especially more than two, carbon atoms or such alkyl moiety which is part of another moiety may be interrupted by heterofunctional groups such as O, S or NR', wherein R' is, for example, H, C1-C 12 Alkyl, C3-C 12 Cycloalkyl or phenyl. They can be interrupted by one or more of these heterofunctional groups, one group in each case usually inserted into a CC bond of the alkyl or alkoxy moiety. If the interrupted moiety is additionally substituted, the substituent is usually not a heteroatom. If two or more spacer groups of the type -O-, -NR'-, -S- occur in one group, they are usually identical.
[0075] Alkylene, such as C3-C4 alkylene, C2-C 12The alkylene group can be derived from the alkyl group defined above by abstracting a H atom from any terminal carbon atom of the alkyl group.
[0076] Cycloalkyl, such as C3-C 18 Cycloalkyl, C3-C 12 Cycloalkyl, C5-C 14 Cycloalkyl, C5-C6 cycloalkyl, including cycloalkyl which may be unsubstituted or substituted with alkyl. Examples are cyclopropyl, cyclobutyl, cyclopentyl, methylcyclopentyl, dimethylcyclopentyl, cyclohexyl, methylcyclohexyl, dimethylcyclohexyl, trimethylcyclohexyl, tert-butylcyclohexyl, butylcyclohexyl, hexylcyclohexyl, dodecylcyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cyclododecyl or 1,4-cyclohexylidenecyclohexyl. Cyclohexyl and cyclopentyl are preferred, and more preferably optionally substituted with C1-C6 cyclohexyl. 12 Cycloalkyl, for example C3-C alkyl, C1-C8 alkyl, C1-C7 alkyl or C1-C5 alkyl 4-substituted cyclohexyl. Cycloalkyl, for example C3-C alkyl, C1-C8 alkyl, C1-C7 alkyl or C1-C5 alkyl 4-substituted cyclohexyl. 18 Cycloalkyl is, for example, tetrahydropyranyl.
[0077] Phenylene-C3-C 18 Examples of cycloalkyl groups are
[0078] Best Substituents such as halogen, CN or OH are preferably located on the alkyl group.
[0079] C3-C 18 Examples of cycloalkylenephenyl groups are Best Substituents such as alkyl, haloalkyl, halogen, CN or OH are preferably located on the phenyl ring.
[0080] Haloalkyl, such as C1-C4 haloalkyl, C1-C6 haloalkyl, C1-C8 haloalkyl, C1-C 12 Haloalkyl, within the given carbon atom limit, may be linear or branched, if possible. Examples are the aforementioned alkyl groups, wherein their H atoms are partially or completely replaced by halogen atoms. Preferred haloalkyl groups are fluoroalkyl groups, more preferably perfluoro groups, most preferably CF3.
[0081] Alkoxy, such as C1-C4 alkoxy, C1-C8 alkoxy, C1-C 12 Alkoxy, C2-C 12 Alkoxy is alkyl-O.
[0082] Alkylthio, such as C1-C4 alkylthio, C1-C 12 Alkylthio, C2-C 12Alkylthio is alkyl-S.
[0083] Aryl, such as C6-C 10 Aryl or C6-C 12 Aryl, within the given carbon atom limit, may be phenyl, 1-naphthyl, 2-naphthyl, biphenyl or ferrocenyl. The aryl may be unsubstituted or substituted.
[0084] Heteroaryl, such as C 2- C 10 Heteroaryl, C2-C5 heteroaryl, may be non-fused or fused heteroaryl, usually containing O, S and / or N. Examples are thienyl, furanyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, thiadiazolyl, Azolyl, iso oxazolyl, pyridyl, triazine, pyrimidinyl, benzo[b]thienyl, benzofuranyl, bipyridyl, isoazaindenyl, indolyl, quinolyl, isoquinolyl, benzothiazolyl, benzisothiazolyl, benzotriazolyl, benzo The heteroaryl group may be unsubstituted or substituted.
[0085] Heteroarylene, such as C4-C 10 Heteroarylene or C4-C6 heteroarylene may be thiophene-2,5-diyl, pyrrole-2,5-diyl, for example Where R 46 It is H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl, preferably H, methyl or ethyl.
[0086] Arylalkyl, such as C7-C 12 Aralkyl, within the given carbon atom limit, can be, for example, benzyl, 2-benzyl-2-propyl, β-phenylethyl (phenylethyl), α,α-dimethylbenzyl, ω-phenylbutyl, ω,ω-dimethyl-ω-phenylbutyl, wherein both aliphatic and aromatic hydrocarbon groups can be unsubstituted or substituted. Preferred examples are benzyl, phenylethyl, α,α-dimethylbenzyl, ω-phenylbutyl, ω-phenyldodecyl and ω-phenyloctadecyl.
[0087] Halogen (Hal) represents I, Br, Cl or F, preferably F or Cl, more preferably F.
[0088] Where Y and an adjacent H together form a group And Q is NR 33 , O or S groups An example could be Best The group is unsubstituted or substituted by a C1-C4 alkyl group, preferably a methyl group or an ethyl group. More preferably, the group is unsubstituted.
[0089] A group in which Y and an adjacent H together form a 5-7 membered heterocyclic ring containing one or two Qs An example could be Where R 50 is H or C1-C4 alkyl, preferably H, methyl or ethyl. The group is unsubstituted or substituted by C1-C4 alkyl, preferably methyl or ethyl. More preferably, the group is unsubstituted and v is 0.
[0090] Where R 2 and R 3 Together they are C3-C4 alkylene Examples of groups may be These groups may be unsubstituted or substituted. Preferably, butylene. The same applies to R 6 and R 7 and R 21 and R 22 .
[0091] Where R 2 and R 3 Together they form a benzo-fused ring Examples of the group may be unsubstituted or substituted
[0092] For example, R 12 and R 13 Together for C2-C 12 Alkylene or replaced by O, S and / or NR 41 Interval C2-C 12 Alkylene NR 12 NR 13 The amine group shown is a cyclic amine where R 12 and R 13 Together with the nitrogen atom to which they are attached, they thus form an aliphatic N-heterocyclic residue containing 2 to 12 ring carbon atoms, the latter optionally being substituted by alkyl. Examples are morpholinyl, thiomorpholinyl, piperidinyl, pyrrolidinyl, or a C1-C8 alkyl substituted variant thereof.
[0093] The term "substituted" means "substituted one or more times", ie possibly 1 to 3 times, preferably 1 or 2 times, more preferably 1 time. If a substituent occurs more than once in a group, it may be different on each occurrence. BRIEF DESCRIPTION OF THE DRAWINGS
[0094] Figure 1is a graph illustrating the absorption spectra of Example 36 in the visible range in an LC cell and after irradiation for 240 hours (solid line: initial absorption spectrum; dashed line: after 240 hours).
[0095] Figure 2 is a graph illustrating the absorption spectra of Example 37 in the visible range in an LC cell and after irradiation for 240 hours (solid line: initial absorption spectrum; dashed line: after 240 hours).
[0096] Figure 3 is a graph illustrating the absorption spectra of Example 38 in the visible range in an LC cell and after irradiation for 240 hours (solid line: initial absorption spectrum; dashed line: after 240 hours).
[0097] Figure 4 is a graph illustrating the absorption spectra of Comparative Example 1 in the LC cell and after irradiation for 240 hours in the visible range (solid line: initial absorption spectrum; dashed line: after 240 hours).
[0098] Preferred groups Ar 1 ,Ar 5 and Ar 10 Can be selected from The residues of
[0099] X is CF3, F, CN, COOR 17 ,CONR 18 R 19 、SO2R 20 or in
[0100] R 1 is C1-C4 alkyl, CF3, F, CN or C1-C4 alkoxy;
[0101] R 2 , R 3 , R 4 , R 5 , R 21 and R 22 Independently of each other and at each occurrence selected from H, F, NO2, CN, COOR 34 , C1-C 12 Alkyl, C1-C substituted by F or CN 12 Alkyl, C1-C 12 Alkoxy, C3-C 12 Cycloalkyl, C3-C substituted by F or CN 12 Cycloalkyl, phenyl or phenyl substituted by F, CN, C1-C8 alkyl or CF3;
[0102] or R2 and R 3 Together they are butylene or form a benzo-fused ring, wherein the butylene or benzo-fused ring is unsubstituted or is replaced by CH3, C2H5, CN, OCH3, OC2H5, NO2, F or SO2R 39 replace;
[0103] or R 21 and R 22 Together, they are butylene, which is unsubstituted or substituted with CH3, C2H5, CN, OCH3, OC2H5, NO2, F or SO2R 40 replace;
[0104] R 17 , R 20 , R 34 , R 39 and R 40 are independently C1-C8 alkyl, C1-C8 alkyl substituted by CN, C5-C 14 Cycloalkyl, C5-C substituted by CN or F 14 Cycloalkyl, phenyl, phenyl substituted by F, CN, C1-C8 alkyl or CF3, phenylene-C5-C 14 Cycloalkyl, phenylene substituted by F or CN -C5-C 14 Cycloalkyl, C5-C 12 Cycloalkylenephenyl or C5-C8 substituted by C1-C8 alkyl, CF3, F or CN 12 Cycloalkylenephenyl;
[0105] R 18 and R 19 H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C 14 Cycloalkyl, C5-C 12 Cycloalkylenephenyl or C5-C8 substituted by C1-C8 alkyl 12 Cycloalkylenephenyl,
[0106] or R 18 and R 19 together with C3-C6 alkylene or replaced by O, S and / or NR 41 Intermitted C3-C6 alkylene;
[0107] R 41 is H, C1-C8 alkyl, C5-C6 cycloalkyl or phenyl; and
[0108] s is 0, 1, or 2.
[0109] The substituent X is preferably para-substituted.
[0110] Ar 1 ,Ar 5 and Ar 10 A more preferred group is selected from The residue of Ar 1 ,Ar 5 and Ar 10 The most preferred group is selected from of residues.
[0111] Ar 1 ,Ar 5 and Ar 10 Particularly preferred groups are selected from of residues.
[0112] Ar 5 and Ar 10 In the compounds of formula (B) may be the same or different. 5 and Ar 10 same.
[0113] Alternatively, preferably Ar 5 and Ar 10 Different compounds of formula (B).
[0114] Ar 1 ,Ar 5 and Ar 10 The substituent X in the 17 ,CONR 18 R 19 、SO2R 20 or in
[0115] R 21 and R 22 independently of each other and at each occurrence selected from H, F, CN, COOR 34 , C1-C8 alkyl, cyclohexyl or phenyl;
[0116] R 17 , R 20 and R 34 are independently C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0117] R 18 and R 19are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenylene -C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0118] or R 18 and R 19 Together they are C5-C6 alkylene or are replaced by O or NR 41 Intermitted C3-C6 alkylene;
[0119] R 41 is H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl; and
[0120] R 21 and R 22 independently of each other and at each occurrence selected from H, F, CN, COOR 34 , C1-C8 alkyl, cyclohexyl or phenyl.
[0121] The substituent X is more preferably CF3, F, CN, COOR 17 ,CONR 18 R 19 、SO2R 20 or in
[0122] R 21 and R 22 Independently of each other and at each occurrence selected from H, F, CN, CO2R 34 , C1-C8 alkyl or phenyl;
[0123] R 17 , R 20 and R 34 are independently C1-C5 alkyl, C6-C 12 Cycloalkyl, phenyl, phenyl substituted by C1-C5 alkyl, phenylene-C6-C 12 Cycloalkyl or C6-C 12 Cycloalkylenephenyl;
[0124] R 18 and R 19 are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenylene -C5-C 12 Cycloalkyl or C6-C 12 Cycloalkylenephenyl;
[0125] or R 18 and R 19 Together they are C5-C6 alkylene or are replaced by O or NR 41Intermitted C3-C6 alkylene; R 41 is H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl; and
[0126] R 21 and R 22 independently of each other and at each occurrence selected from H, F, CN, COOR 34 , C1-C8 alkyl, cyclohexyl or phenyl.
[0127] Most preferably, the substituent X is CF3, F, CN or COOR 17 ,in
[0128] R 17 It is C1-C5 alkyl, C6-C 12 Cycloalkyl, phenyl, phenyl substituted by C1-C5 alkyl, phenylene-C6-C 12 Cycloalkyl or C6-C 12 Cycloalkylphenyl; especially C1-C5 alkyl, C6-C 12 Cycloalkyl or phenyl;
[0129] Ar 1 ,Ar 5 and Ar 10 The substituent R 1 It can be C1-C4 alkyl, CF3, F, CN or C1-C4 alkoxy, preferably C1-C4 alkyl, CF3, F or CN; more preferably CH3 or F, most preferably CH3.
[0130] Particularly preferred are groups Ar in which s is 0 1 ,Ar 5 and Ar 10 .
[0131] Ar 1 ,Ar 5 and Ar 10 Preferred substituents R in 2 , R 3 , R 4 and R 5 independently of each other and at each occurrence selected from H, F, CN, COOR 34 , C1-C8 alkyl, cyclohexyl or phenyl; or R 2 and R 3 Together they form a benzo-fused ring which is unsubstituted or substituted with CH3, C2H5 or CN; and
[0132] R 34 It is C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl.
[0133] Ar 1 ,Ar 5 and Ar 10 More preferably, the substituent R 2 , R 3 , R 4 and R 5 Independently of each other and at each occurrence selected from H, F, CN, CO2R 34 , C1-C8 alkyl or phenyl;
[0134] or R 2 and R 3 Together they form a benzo-fused ring which is unsubstituted or substituted with CH3, C2H5 or CN; and
[0135] R 34 It is C1-C5 alkyl, C6-C 12 Cycloalkyl, phenyl, phenyl substituted by C1-C5 alkyl, phenylene-C6-C 12 Cycloalkyl or C6-C 12 The cycloalkylenephenyl group is preferably unsubstituted.
[0136] Ar 1 ,Ar 5 and Ar 10 R 2 , R 3 , R 4 and R 5 In particular, independently of one another, H, F, C1-C7 alkyl or CF3;
[0137] or R 2 and R 3 Together they form a benzo-fused ring which is unsubstituted or substituted by CH3, C2H5 or CN, preferably unsubstituted.
[0138] Preferred groups Ar 2 ,Ar 3 ,Ar 6 ,Ar 7 ,Ar 8 and Ar 9 Independently and at each occurrence, selected from in
[0139] R 8 and R 9 Independently from each other and at each occurrence, CH3, CF3, F, CN or OCH3; more preferably CH3;
[0140] t and u are independently 0, 1 or 2.
[0141] Preferred groups Ar 4 Can be C2-C 10 Heteroaryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12 Alkylthio, OH, halogen, CF3, NR 12 R 13 、CO2R 14 , COR 15 、SO2R 16 , NO2 or CN substituted C2-C 10 heteroaryl residues;
[0142] Y is H, C1-C 12 Alkyl, substituted by OH or NH2 and / or NR 23 or C1-C in O interval 12 Alkyl, CF3, C7-C 12 Aralkyl, NR 24 R 25 , F, CN, OH, C1-C 12 Alkoxy, C1-C 12 Alkylthio, COOR 26 , C6-C 12 Aryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12 Alkylthio, CN, F, OH or NR 27 R 28 Substituted C6-C 12 Aryl, C2-C 10 Heteroaryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12 Alkylthio, OH, F, CN or NR 29 R 30 Substituted C2-C 10 Heteroaryl, C5-C 18 Cycloalkyl or CF3, F, CN, OH, C1-C 12 Alkoxy, C1-C 12 Alkylthio or NR 31 R 32 C5-C substituted and / or interrupted by one or more O 18 Cycloalkyl;
[0143] Or Y and an adjacent H together form a group or a 5-7 membered heterocyclic ring containing Q,
[0144] Q is NR 33 , O or S;
[0145] The heterocycle is unsubstituted or substituted with CH3;
[0146] R 10 is selected at each occurrence from C1-C8 alkyl, CF3, F, C1-C8 alkoxy, OH or CN;
[0147] R 11 In each occurrence it is CH3 or C2H5;
[0148] R 14 , R 15 , R 16 and R 26 are independently C1-C8 alkyl, C1-C8 alkyl substituted by CN, C5-C 14 Cycloalkyl, C5-C substituted by CN or F 14 Cycloalkyl, phenyl, phenyl substituted by F, CN, C1-C8 alkyl or CF3, phenylene-C5-C 14 Cycloalkyl, phenylene substituted by F or CN -C5-C 14 Cycloalkyl, C5-C 12 Cycloalkylenephenyl or C5-C8 substituted by C1-C8 alkyl, CF3, F or CN 12 Cycloalkylenephenyl;
[0149] R 12 , R 13 , R 24 , R 25 , R 27 , R 28 , R 29 , R 30 , R 31 and R 32 are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C 14 Cycloalkyl, C5-C 12 Cycloalkylenephenyl or C5-C8 substituted by C1-C8 alkyl 12 Cycloalkylenephenyl,
[0150] or R 12 and R 13 , R 24 and R 25 , R 27 and R 28 , R29 and R 30 or R 31 and R 32 together with C3-C6 alkylene or replaced by O, S and / or NR 41 Intermitted C3-C6 alkylene;
[0151] R 23 , R 33 and R 41 are independently H, C1-C8 alkyl, C5-C6 cycloalkyl or phenyl;
[0152] v is 0, 1, or 2; and
[0153] w is 0, 1, 2, 3, or 4.
[0154] More preferred groups Ar 4 yes
[0155] The residues, especially
[0156] The group.
[0157] Thienyl Preferably, it is unsubstituted, of the formula The group or formula of groups, among which
[0158] R 47 It is C1-C6 alkyl, C1-C6 alkoxy, NR 12 R 13 、CO2R 14 or NO2;
[0159] R 14 It is C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0160] R 12 and R 13 are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenylene -C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0161] or R 12 and R 13 Together they are C5-C6 alkylene or are replaced by O or NR 41Intermitted C3-C6 alkylene; and
[0162] R 41 It is H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl.
[0163] Mode In particular, the group is unsubstituted or of the formula of groups, among which
[0164] R 47 It is C1-C6 alkyl, C1-C6 alkoxy, NR 12 R 13 or NO2;
[0165] R 12 and R 13 are independently C1-C6 alkyl,
[0166] or R 12 and R 13 Together with the N atom, it forms a pyrrolidinyl ring, a piperidinyl ring, a morpholinyl ring, a piperazinyl ring or an N-substituted piperazinyl ring substituted by a C1-C4 alkyl group.
[0167] Mode The group is preferably of the formula The group, formula The group or formula of groups, among which
[0168] R 48 It is C1-C6 alkyl, C1-C6 alkoxy, NR 12 R 13 、CO2R 14 or NO2;
[0169] R 14 It is C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0170] R 12 and R 13 are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenylene -C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0171] or R 12 and R 13 Together they are C5-C6 alkylene or are replaced by O or NR 41Intermitted C3-C6 alkylene; and
[0172] R 41 and R 49 It is H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl.
[0173] Mode The group is especially of the formula The group, formula of groups, among which
[0174] R 48 Selected from C1-C6 alkyl, C1-C6 alkoxy, NR 12 R 13 or NO2;
[0175] R 12 and R 13 are independently C1-C6 alkyl,
[0176] or R 12 and R 13 together with the N atom, form a pyrrolidinyl ring, a piperidinyl ring, a morpholinyl ring or a piperazinyl ring or an N-substituted piperazinyl ring substituted by a C1-C4 alkyl group, and
[0177] R 49 It is H or C1-C4 alkyl.
[0178] Ar 4 The substituent Y in the 24 R 25 , F, CN, OH, C1-C8 alkoxy, C1-C8 alkylthio, COOR 26 , phenyl, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthio, F, CN or NR 27 R 28 Substituted phenyl, or C5-C 14 Cycloalkyl;
[0179] Or Y and an adjacent H together form a group or a 5-7 membered heterocyclic ring containing Q,
[0180] Q is NR 33 or O;
[0181] The heterocyclic group is unsubstituted or substituted with CH3;
[0182] R 26 It is C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C 14Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0183] R 24 , R 25 , R 27 and R 28 are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenylene -C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0184] or R 24 and R 25 or R 27 and R 28 Together they are C5-C6 alkylene or are replaced by O or NR 41 Intermitted C3-C6 alkylene; and
[0185] R 33 and R 41 are independently H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl.
[0186] The substituent Y is more preferably H, C1-C8 alkyl, NR 24 R 25 , F, CN, OH, C1-C8 alkoxy, C1-C8 alkylthio, COOR 26 , phenyl, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthio or NR 27 R 28 Substituted phenyl, or C5-C 14 Cycloalkyl;
[0187] Or Y and an adjacent H together form a group or a 5-6 membered heterocyclic ring containing Q,
[0188] Q is NR 33 or O;
[0189] The heterocyclic group is unsubstituted or substituted with CH3;
[0190] R 26 It is C1-C5 alkyl, C6-C 12 Cycloalkyl, phenyl, phenyl substituted by C1-C5 alkyl, phenylene-C6-C 12 Cycloalkyl or C6-C 12 Cycloalkylenephenyl;
[0191] R 24 , R 25 , R 27 and R 28are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenylene -C6-C 12 Cycloalkyl or C6-C 12 Cycloalkylenephenyl;
[0192] or R 24 and R 25 or R 27 and R 28 Together they are C5-C6 alkylene or are replaced by O or NR 41 Intermitted C3-C6 alkylene; and
[0193] R 33 and R 41 are independently H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl.
[0194] The most preferred substituent Y is H, C1-C7 alkyl, C1-C7 alkyl substituted by OH or NH2, NR 24 R 25 , F, CN, OH, C1-C6 alkoxy, COOR 26 , phenyl, C1-C7 alkyl, C1-C6 alkoxy or NR 27 R 28 Substituted phenyl, or C5-C6 cycloalkyl;
[0195] Or Y and an adjacent H together form a group or a 5-6 membered heterocyclic ring containing Q,
[0196] Q is NR 33 or O;
[0197] The heterocycle is unsubstituted or substituted with CH3;
[0198] R 26 It is C1-C5 alkyl, C6-C 12 Cycloalkyl, phenyl, phenyl substituted by C1-C5 alkyl, phenylene-C6-C 12 Cycloalkyl or C6-C 12 Cycloalkylenephenyl;
[0199] R 24 , R 25 , R 27 and R 28 are independently H or C1-C5 alkyl,
[0200] or R 24 and R 25 or R 27 and R 28 Together they are C5-C6 alkylene or are replaced by O or NR41 Intermitted C5-C6 alkylene; and
[0201] R 33 and R 41 are independently H or C1-C4 alkyl.
[0202] Ar 4 The substituent R 10 It can be selected from C1-C8 alkyl, CF3, F, C1-C8 alkoxy, OH or CN, preferably C1-C7 alkyl, CF3, F, Cl, Br, C1-C6 alkoxy, OH or CN.
[0203] Ar 4 The substituent R 11 It can be selected from CH3 or C2H5.
[0204] The group is preferably unsubstituted or of the formula A group of The group.
[0205] Preferably the group L is a single bond or is selected from ;
[0206] R 42 and R 44 independently of one another and at each occurrence are selected from C1-C4 alkyl, CF3, C1-C4 alkoxy, F, OH, CN or COOR 45 ;
[0207] Z and Z' are independently NR 46 , O or S; especially S or NR 46 , especially S;
[0208] or R 44 The two adjacent groups of form a benzo-fused ring, and the benzo-fused ring is unsubstituted or replaced by R 44 replace;
[0209] R 45 is CH3 or C2H5;
[0210] R 46 is H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl;
[0211] k and y are independently 0, 1 or 2; and
[0212] x and x' are independently 1 or 2.
[0213] More preferably, the group L is selected from ;
[0214] R 42 and R 44 independently of one another and at each occurrence are selected from C1-C4 alkyl, CF3, C1-C4 alkoxy, F, OH, CN or COOR 45 ;
[0215] Z and Z' are independently S or NR 46 ;
[0216] R 45 is CH3 or C2H5;
[0217] R 46 is H or C1-C4 alkyl,
[0218] k and y are independently 0, 1 or 2; and
[0219] x and x' are independently 1 or 2.
[0220] Particularly preferably selected from A group in which R 42 and R 44 Independently from each other and at each occurrence, selected from CH3 or OCH3;
[0221] k and y are independently 0, 1 or 2, especially 0; and
[0222] x and x' are 1.
[0223] The compounds of formula (A) and (B) may contain phenylene, naphthylene or phenylene and naphthylene as the group Ar 2 ,Ar 3 ,Ar 6 ,Ar 7 ,Ar 8 and Ar 9 .
[0224] Therefore, in a preferred aspect the invention relates to a compound having one of the following formulae:
[0225]
[0226]
[0227] Among them, Ar 1 ,Ar 5 and Ar 10 are independently selected from
[0228] The residues of
[0229] Ar 4 yes C2-C 10 Heteroaryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12 Alkylthio, OH, halogen, CF3, NR 12 R 13 、CO2R 14 , COR 15 、SO2R 16 , NO2 or CN substituted C2-C 10 heteroaryl residues;
[0230] X is CF3, F, CN, COOR 17 ,CONR 18 R 19 、SO2R 20 or
[0231] Y is H, C1-C 12 Alkyl, substituted by OH or NH2 and / or NR 23 or C1-C in O interval 12 Alkyl, CF3, C7-C 12 Aralkyl, NR 24 R 25 , F, CN, OH, C1-C 12 Alkoxy; C1-C 12 Alkylthio, COOR 26 , C6-C 12 Aryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12 Alkylthio, CN, F, OH or NR 27 R 28 Substituted C6-C 12 Aryl, C2-C 10 Heteroaryl, C1-C 12 Alkyl, C1-C 12 Alkoxy, C1-C 12 Alkylthio, OH, F, CN or NR 29 R 30 Substituted C2-C 10 Heteroaryl, C5-C 18 Cycloalkyl or CF3, F, CN, OH, C1-C 12 Alkoxy, C1-C 12 Alkylthio or NR 31 R 32 C5-C substituted and / or interrupted by one or more O 18 Cycloalkyl;
[0232] Or Y and an adjacent H together form a group or a 5-7 membered heterocyclic ring containing one or two Qs,
[0233] Q is NR 33 , O or S;
[0234] The group or the heterocycle is unsubstituted or substituted with CH3;
[0235] R 1 is C1-C4 alkyl, CF3, F, CN or C1-C4 alkoxy;
[0236] R 2 , R 3 , R 4 , R 5 , R 21 and R 22 Independently of each other and at each occurrence selected from H, F, NO2, CN, COOR 34 , C1-C 12 Alkyl, C1-C substituted by F or CN 12 Alkyl, C1-C 12 Alkoxy, C3-C 12 Cycloalkyl, C3-C substituted by F or CN 12 Cycloalkyl, phenyl, or phenyl substituted by F, CN, C1-C8 alkyl or CF3;
[0237] or R 2 and R 3 Together they are butylene or form a benzo-fused ring, wherein the butylene or benzo-fused ring is unsubstituted or is replaced by CH3, C2H5, CN, OCH3, OC2H5, NO2, F or SO2R 39 replace;
[0238] or R 21 and R 22 Together, they are butylene, which is unsubstituted or substituted with CH3, C2H5, CN, OCH3, OC2H5, NO2, F or SO2R 40 replace;
[0239] R 8 and R 9 Independently from each other and at each occurrence, CH3, CF3, F, CN or OCH3;
[0240] R 10 is selected at each occurrence from C1-C8 alkyl, CF3, F, C1-C8 alkoxy, OH or CN;
[0241] R 11In each occurrence it is CH3 or C2H5;
[0242] R 14 , R 15 , R 16 , R 17 , R 20 , R 26 , R 34 , R 39 and R 40 are independently C1-C8 alkyl, C1-C8 alkyl substituted by CN, C5-C 14 Cycloalkyl, C5-C substituted by CN or F 14 Cycloalkyl, phenyl, phenyl substituted by F, CN, C1-C8 alkyl or CF3, phenylene-C5-C 14 Cycloalkyl, phenylene substituted by F or CN -C5-C 14 Cycloalkyl, C5-C 12 Cycloalkylenephenyl or C5-C8 substituted by C1-C8 alkyl, CF3, F or CN 12 Cycloalkylenephenyl;
[0243] R 12 , R 13 , R 18 , R 19 , R 24 , R 25 , R 27 , R 28 , R 29 , R 30 , R 31 and R 32 are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C 14 Cycloalkyl, C5-C 12 Cycloalkylenephenyl or C5-C8 substituted by C1-C8 alkyl 12 Cycloalkylenephenyl,
[0244] or R 12 and R 13 , R 18 and R 19 , R 24 and R 25 , R 27 and R 28 , R 29 and R 30 or R 31 and R 32 together with C3-C6 alkylene or replaced by O, S and / or NR 41Intermitted C3-C6 alkylene;
[0245] R 23 , R 33 and R 41 are independently H, C1-C8 alkyl, C5-C6 cycloalkyl or phenyl;
[0246] L is a single bond or selected from ;
[0247] R 42 and R 44 independently of one another and at each occurrence are selected from C1-C4 alkyl, CF3, C1-C4 alkoxy, F, OH, CN or COOR 45 ;
[0248] Z and Z' are independently NR 46 , O or S;
[0249] or R 44 The two adjacent groups of form a benzo-fused ring, and the benzo-fused ring is unsubstituted or replaced by R 44 replace;
[0250] R 45 is CH3 or C2H5;
[0251] R 46 is H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl;
[0252] m, n, p and q are independently 0 or 1,
[0253] The condition is that the sum m+n ≥ 1;
[0254] k, s, t, u, v and y are independently 0, 1 or 2;
[0255] w is 0, 1, 2, 3, or 4; and
[0256] x and x' are independently 1 or 2.
[0257] Preference is given to compounds of the formula (A1), (A2) or (A3) wherein n is 0 and m is 1.
[0258] Ar 1 ,Ar 5 and Ar 10 They can be selected from various aromatic or heteroaromatic groups. Preferably, they are selected from groups having electron-withdrawing functional groups.
[0259] Therefore, preferred are compounds of formula (A), (B) or formula (A1), (A2), (A3), (B1), (B2), (B3) or (B4), wherein
[0260] Ar 1 ,Ar 5 and Ar 10 are independently selected from
[0261] The residues of
[0262] Ar 4 yes The residues of
[0263] X is CF3, F, CN, COOR 17 ,CONR 18 R 19 、SO2R 20 or
[0264] Y is H, C1-C8 alkyl, CF3, NR 24 R 25 , F, CN, OH, C1-C8 alkoxy, C1-C8 alkylthio, COOR 26 , phenyl, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthio, F, CN or NR 27 R 28 Substituted phenyl, or C5-C 14 Cycloalkyl;
[0265] Or Y and an adjacent H together form a group or a 5-7 membered heterocyclic ring containing one or two Qs,
[0266] Q is NR 33 or O;
[0267] The group or the heterocyclic group is unsubstituted or substituted with CH3;
[0268] R 1 is CH3, CF3, F or CN;
[0269] R 2 , R 3 , R 4 , R 5 , R 21 and R 22 independently of each other and at each occurrence selected from H, F, CN, COOR 34 , C1-C8 alkyl, cyclohexyl or phenyl;
[0270] or R 2 and R 3Together they form a benzo-fused ring, which is unsubstituted or substituted with CH3, C2H5 or CN;
[0271] R 10 is selected at each occurrence from C1-C8 alkyl, CF3, F, C1-C8 alkoxy, OH or CN;
[0272] R 11 In each occurrence it is CH3 or C2H5;
[0273] R 14 , R 17 , R 20 , R 26 and R 34 are independently C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenyl substituted by C1-C8 alkyl, phenylene-C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0274] R 12 , R 13 , R 18 , R 19 , R 24 , R 25 , R 27 and R 28 are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenylene -C5-C 14 Cycloalkyl or C5-C 12 Cycloalkylenephenyl;
[0275] or R 12 and R 13 , R 18 and R 19 , R 24 and R 25 or R 27 and R 28 Together they are C5-C6 alkylene or are replaced by O or NR 41 Intermitted C3-C6 alkylene;
[0276] R 33 , R 41 and R 49 are independently H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl;
[0277] R 47 and R 48 independently of one another and at each occurrence are selected from C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthio, OH, F, CF3, NR12 R 13 、CO2R 14 or NO2;
[0278] or R 47 or R 48 The two adjacent groups form a benzo-fused ring, which is unsubstituted or substituted with C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthio, OH, F, CF3, NR 12 R 13 、CO2R 14 or NO2 substitution;
[0279] r and r' are 0, 1 or 2;
[0280] s is 0 or 1;
[0281] v is 0, 1, or 2; and
[0282] w is 0, 2, or 4.
[0283] The divalent group L may be a direct bond, an arylene group or a heteroarylene group, preferably an arylene group or a heteroarylene group.
[0284] Therefore, preferred are compounds of formula (A) or (B), wherein
[0285] L is selected from ;
[0286] R 42 and R 44 independently of one another and at each occurrence are selected from C1-C4 alkyl, CF3, C1-C4 alkoxy, F, OH, CN or COOR 45 ;
[0287] Z and Z' are independently S or NR 46 ;
[0288] R 45 is CH3 or C2H5;
[0289] R 46 is H or C1-C4 alkyl,
[0290] k and y are independently 0, 1 or 2; and
[0291] x and x' are 1 or 2.
[0292] More preferably, the compound is of the following formula (A1), (A2), (A3), (B1), (B2), (B3) or (B4), wherein
[0293] L is selected from ;
[0294] R 42 and R 44 independently of one another and at each occurrence are selected from C1-C4 alkyl, CF3, C1-C4 alkoxy, F, OH, CN or COOR 45 ;
[0295] Z and Z' are S;
[0296] R 45 is CH3 or C2H5;
[0297] k and y are independently 0, 1 or 2; and
[0298] x and x' are 1 or 2.
[0299] Preference is given to compounds (A1), (A2) or (A3) in which n is 0 and m is 1.
[0300] Therefore, preferred compounds of formula (A) or (B) are compounds of formula (A1-1), (A2-1), (A3-1), (B1-1), (B1-2), (B2-1), (B2-2), (B3-1) or (B4-1) having one of the following formulae:
[0301]
[0302]
[0303]
[0304] Among them, Ar 1 ,Ar 5 and Ar 10 are independently selected from The residues of
[0305] Ar 4 yes The residues of
[0306] X is CF3, F, CN, COOR 17 ,CONR 18 R 19 、SO2R 20 or
[0307] Y is H, C1-C8 alkyl, NR 24 R 25 , F, CN, OH, C1-C8 alkoxy, C1-C8 alkylthio, COOR 26 , phenyl, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthio or NR27 R 28 Substituted phenyl, or C5-C 14 Cycloalkyl;
[0308] Or Y and an adjacent H together form a group or a 5-6 membered heterocyclic ring containing one or two Qs,
[0309] Q is NR 33 or O;
[0310] The group or the heterocyclic group is unsubstituted or substituted with CH3;
[0311] R 1 is CH3, CF3, F or CN;
[0312] R 2 , R 3 , R 4 , R 5 , R 21 and R 22 Independently of each other and at each occurrence selected from H, F, CN, CO2R 34 , C1-C8 alkyl or phenyl;
[0313] or R 2 and R 3 Together they form a benzo-fused ring, which is unsubstituted or substituted with CH3, C2H5 or CN;
[0314] R 8 and R 9 Independently of each other and at each occurrence, CH3;
[0315] R 10 is selected at each occurrence from C1-C8 alkyl, CF3, F, C1-C8 alkoxy, OH or CN;
[0316] R 11 In each occurrence it is CH3 or C2H5;
[0317] R 14 , R 17 , R 20 , R 26 and R 34 are independently C1-C5 alkyl, C6-C 12 Cycloalkyl, phenyl, phenyl substituted by C1-C5 alkyl, phenylene-C6-C 12 Cycloalkyl or C6-C 12 Cycloalkylenephenyl;
[0318] R 12 , R13 , R 18 , R 19 , R 24 , R 25 , R 27 and R 28 are independently H, C1-C8 alkyl, C5-C 14 Cycloalkyl, phenyl, phenylene -C6-C 12 Cycloalkyl or C6-C 12 Cycloalkylenephenyl;
[0319] or R 12 and R 13 , R 18 and R 19 , R 24 and R 25 or R 27 and R 28 Together they are C5-C6 alkylene or are replaced by O or NR 41 Intermitted C3-C6 alkylene;
[0320] R 33 , R 41 and R 49 are independently H, C1-C4 alkyl, C5-C6 cycloalkyl or phenyl;
[0321] L is selected from ;
[0322] R 42 and R 44 Independently from each other and at each occurrence, selected from CH3 or OCH3;
[0323] R 47 and R 48 are independently selected from C1-C6 alkyl, C1-C6 alkoxy, NR 12 R 13 、CO2R 14 or NO2;
[0324] k, t, v and y are independently 0, 1 or 2;
[0325] x and x' are 1;
[0326] r, r', s and u are independently 0 or 1; and
[0327] w is 0, 2, or 4.
[0328] The compounds of formula (A) or (B), preferably the compounds of formula (A1), (A2), (A3), (B1), (B2), (B3) or (B4), more preferably the compounds of formula (A1-1), (A2-1), (A3-1), (B1-1), (B1-2), (B2-1), (B2-2), (B3-1) or (B4-1) especially include a para-substituted aryl or thiazolyl group as Ar 1 ,Ar 5 and Ar 10 .
[0329] Particularly preferred are compounds of formula (B1-1), (B1-2), (B2-1), (B2-2) or (B3-1), wherein Ar 5 and Ar 10 same.
[0330] Therefore, more preferred are compounds of formula (A1-1), (A2-1), (A3-1), (B1-1), (B1-2), (B2-1), (B2-2), (B3-1) or (B4-1), wherein
[0331] Ar 1 ,Ar 5 and Ar 10 are independently selected from The residues of Ar 5 and Ar 10 same;
[0332] Ar 4 yes The residues of
[0333] X is CF3, F, CN or COOR 17 ;
[0334] R 2 and R 3 are independently H, F, C1-C7 alkyl or CF3;
[0335] or R 2 and R 3 Together they form a benzo-fused ring, which is unsubstituted or substituted with CH3, C2H5 or CN;
[0336] R 10 is C1-C7 alkyl, CF3, F, Cl, Br, C1-C6 alkoxy, OH or CN;
[0337] Y is H, C1-C7 alkyl, C1-C7 alkyl substituted by OH or NH2, NR 24 R 25, F, CN, OH, C1-C6 alkoxy, COOR 26 , phenyl, C1-C7 alkyl, C1-C6 alkoxy or NR 27 R 28 Substituted phenyl, or C5-C6 cycloalkyl;
[0338] Or Y and an adjacent H together form a group or a 5-6 membered heterocyclic ring containing one or two Qs,
[0339] Q is NR 33 or O;
[0340] The group or the heterocycle is unsubstituted or substituted with CH3;
[0341] R 14 , R 17 and R 26 are independently C1-C5 alkyl, C6-C 12 Cycloalkyl, phenyl, phenyl substituted by C1-C5 alkyl, phenylene-C6-C 12 Cycloalkyl or C6-C 12 Cycloalkylenephenyl;
[0342] R 12 , R 13 , R 24 , R 25 , R 27 and R 28 are independently H or C1-C5 alkyl, or R 12 and R 13 , R 24 and R 25 or R 27 and R 28 Together they are C5-C6 alkylene or are replaced by O or NR 41 Intermitted C5-C6 alkylene;
[0343] R 33 , R 41 and R 49 are independently H or C1-C4 alkyl,
[0344] R 47 and R 48 Independently of each other and at each occurrence are selected from C1-C6 alkyl, C1-C6 alkoxy,
[0345] NR 12 R 13 、CO2R 14 or NO2;
[0346] L is selected from ;
[0347] v is 0, 1, or 2; and
[0348] r and r' are 0 or 1.
[0349] The compounds of the formulae (A) and (B) according to the invention can be prepared by condensation of amino-substituted azo compounds with aldehydes and, if necessary, further purified in analogy to known methods, in particular in the field of azo dye chemistry.
[0350] Thus, in another aspect, the invention relates to a process for preparing a compound of formula (A) or (B) as defined in any aspect above,
[0351] - in the case of compounds of formula (A) by condensing an amino-substituted azo compound of formula (AA) with an aldehyde of formula (AB):
[0352]
[0353] - in the case of compounds of formula (B) by condensing an amino-substituted azo compound of formula (BA) with a dialdehyde of formula (BB):
[0354]
[0355] The residues and symbols in compounds (AA), (AB), (BA) and (BB) have been described above in the definitions of compounds (A) and (B).
[0356] Suitable condensation conditions are known in the art and are described, for example, in reference books such as Enamines-Synthesis, Structures and Reactions, AG Cook, published by Marcel Dekker, New-York (1969) or PW Hickmott, Tetrahedron 38, 1975-2050; 3363-3446 (1982).
[0357] Typically, equimolar amounts of a compound of formula (AA) and a compound of formula (AB) are reacted in a solvent at elevated temperature, optionally under acidic catalysis, to form a compound of formula (A). The amount of (AB) may vary from equimolar to excessive to ensure that the reaction is complete. A compound of formula (B) is typically prepared by reacting 1 equivalent of a dialdehyde of formula (BB) with 2 equivalents of a compound of formula (BA).
[0358] The temperature may be in the range of 40-180° C., preferably 70-160° C. Suitable solvents may be alcohols, such as ethanol, n-propanol or butanol, solvents which allow azeotropic distillation of water, such as toluene, o-dichlorobenzene or xylene, or polar aprotic solvents, such as N,N-dimethylformamide. Examples of suitable catalysts are acetic acid, p-toluenesulfonic acid, methanesulfonic acid or formic acid. The water formed during the reaction is usually removed by a water separator using a water absorbent such as a suitable molecular sieve or by azeotropic distillation.
[0359] Azo compounds (AA) and (AB) are commercially available and / or can be prepared as described in US 4,565,424 (see for example columns 9-10) or in the Examples section of WO 2011 / 157614 A1. In addition, they can be prepared according to the methods described in "Dichroic Dyes for Liquid Crystal Display" by AVIvashchenko, CRC publication, 1994.
[0360] Aldehydes (AB) and (BB) are commercially available or can be prepared as known in the art.
[0361] The compounds of formula (A) and (B) thus obtained can be isolated and purified by conventional methods known to those skilled in the art.
[0362] The compounds of formula (A) and (B) of the present invention are characterized by a high dichroic ratio. Preferably, the dichroic ratio (parallel extinction / perpendicular extinction) of the azo-azomethine dye of formula (A) or (B), measured as a 2 wt. % solution in the nematic liquid crystal mixture MLC2132 commercially available from Merck KGaA, Germany, at room temperature (i.e. 25° C.) in a thin film cell with a cell gap of 5 μm, is ≥7.5, preferably ≥8, more preferably ≥10 in the liquid crystal material MLC2132.
[0363] The compounds of formula (A) and (B) are also characterized by good solubility in liquid crystal materials. The solubility of the compounds of formula (A) and (B) in a standard liquid crystal mixture, for example in MLC2132 (at room temperature (i.e. 25° C.)) is preferably ≥0.1 wt %, more preferably ≥0.2 wt %, and most preferably ≥0.3 wt %, based on the total amount of the liquid crystal mixture. A mixture of two or more compounds of formula (A) and (B) may have a higher solubility in liquid crystal materials.
[0364] The compounds of formula (A) and (B) can be used as single dichroic dyes.
[0365] The compounds of formula (A) and (B) can also be used as mixtures comprising at least one compound of formula (A) and / or (B). Thus, a dichroic dye mixture can comprise at least one compound of formula (A) or can comprise at least one compound of formula (B) or can comprise at least one compound of formula (A) and at least one compound of formula (B).
[0366] Optionally, the dichroic dye mixture may comprise further dichroic dyes other than the compound of formula (A) or (B).
[0367] Thus, the present invention relates in another aspect to a dichroic dye mixture comprising one or more compounds of formula (A) or (B) as defined in any aspect herein and optionally, one or more further dichroic dyes.
[0368] The dichroic dye mixture generally contains one or more compounds of formula (A) and / or (B), preferably 1, 2, 3, 4 or 5 compounds of formula (A) and / or (B). The dichroic dye mixture may also contain one or more other dichroic dyes different from the compounds of formula (A) or (B), preferably 1, 2, 3, 4 or 5 other dichroic dyes.
[0369] Typically a mixture of dichroic dyes is used to achieve a certain colour.The other dichroic dye may be selected from any known dichroic dyes, such as dichroic azo dyes, dichroic anthraquinone dyes or dichroic azomethine dyes other than compounds of formula (A) or (B).
[0370] A dichroic dye mixture is a dichroic dye mixture having a certain hue or a black dichroic dye mixture.
[0371] A dichroic dye mixture is preferably a dichroic dye mixture having a certain hue.
[0372] Alternatively, a dichroic dye mixture is preferably a black dichroic dye mixture. Usually at least two or three dyes are required to achieve the required black, for example by mixing yellow, blue and red dyes or magenta, cyan and yellow dyes or violet, green-blue and orange dyes. For example, a black dichroic dye mixture can comprise a yellow dye with a maximum absorption of 400-500nm, a magenta dye with a maximum absorption of 500-580 and a cyan dye with a maximum absorption of 580-700nm.
[0373] The dye mixture comprises in particular compounds of formula (A) and / or (B) and a blue dichroic dye, such as an azo dye or an anthraquinone dye, preferably an azo dye. It has been found that the dichroic dye mixture can have better light stability than dichroic dye mixtures based on azo dyes.
[0374] The compound of formula (A) or (B) or the dichroic dye mixture is usually compounded with a liquid crystal material (LC material) to form a liquid crystal composition.
[0375] The compound of formula (A) or (B) or the dichroic dye mixture is usually soluble in the LC material according to known techniques such as forming a pre-solution of one or more dyes in a solvent, especially a solvent with a high vapor pressure, such as a lower alkyl ether, a hydrocarbon or a halogenated hydrocarbon such as dichloromethane, mixing the pre-solution with the LC material and removing the solvent under reduced pressure and / or heating. The LC material is usually commercially available. The use of dyes in the liquid crystal material, the type of liquid crystal material, the assembly and testing methods of the liquid crystal unit are known in the art. Some are described, for example, in US-4565424 (see, for example, columns 13-18).
[0376] The compounds of formula (A) and / or (B) or the dichroic dye mixture of the invention may be present in the liquid crystal composition in an amount of 0.01 to 10% by weight, preferably 0.05 to 7% by weight, more preferably 0.1 to 5% by weight.
[0377] Thus, the present invention relates in another aspect to a liquid crystal composition comprising a liquid crystal material and at least one compound of formula (A) and / or (B) as defined in any aspect herein or a dichroic dye mixture as defined in any aspect above.
[0378] The LC material in the liquid crystal composition of the present invention generally comprises a single compound or a plurality of different compounds.
[0379] The LC material of the liquid-crystal composition of the present invention generally comprises at least one compound in the form of molecules having an elongated shape, which are significantly longer in one spatial direction than in the other two spatial directions.
[0380] More preferably, the liquid crystal composition according to the invention comprises an LC material comprising at least one compound containing structural units based on 1,4-phenylene and / or 1,4-cyclohexylene, preferably 2 to 20 compounds, particularly preferably 2 to 18 compounds, more preferably 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 compounds containing structural units based on 1,4-phenylene and / or 1,4-cyclohexylene.
[0381] Suitable compounds that can be used as LC materials for the liquid crystal composition are known in the art. Suitable LC materials are described, for example, in EP 1352943 A1, EP 3048159 A1 or EP 2725083 A2. Further suitable ones are, for example, those produced by Merck KGaA of Germany under the trade name or Commercially available liquid crystal mixture.
[0382] The liquid crystal composition of the present invention comprises at least one compound of formula (A) or (B) as defined in any aspect above and a liquid crystal material. In addition to the aforementioned compounds, other compounds may be present in the liquid crystal composition, such as solvents, chiral dopants, surfactants, stabilizers, such as antifungal agents or antibacterial agents or disinfectants, anti-cratering agents, non-liquid crystal polymerizable monomers, non-liquid crystal binder polymers, polymerizable LC dye monomers, photoinitiators, UV light absorbers or free radical scavengers.
[0383] Depending on the end use, suitable LC materials can be selected from those known to the person skilled in the art. Various phases, such as smectic or nematic phases are known to give anisotropic effects.
[0384] The compounds of formula (A) and (B), dichroic dye mixtures or liquid crystal compositions of the present invention can be used in various applications, for example as guests in guest-host LC application media to form light absorbing anisotropic elements.
[0385] Therefore, the present invention relates in another aspect to a light absorbing anisotropic element comprising a compound of formula (A) or (B) as defined in any aspect herein or a dichroic dye mixture as defined in any aspect herein or a liquid crystal composition as defined in any aspect herein.
[0386] The term "light absorption anisotropic element" as used herein is a polarizing element containing a dichroic dye, which has anisotropy of electromagnetic properties in any two directions selected from all three directions in the thickness direction and any two orthogonal directions on the inner surface of the dichroic dye layer. Examples of the electromagnetic properties include optical properties such as absorption and reflection, and electrical properties such as resistance and capacitance.
[0387] The method of manufacturing a light-absorbing anisotropic element of the present invention generally comprises:
[0388] a) dissolving the compound of formula (A) or (B) or the dichroic dye mixture of the present invention in an LC material to form a liquid crystal layer comprising the LC composition, and
[0389] b) providing a step of providing a means for orienting the compound of formula (A) or (B) or the dichroic dye mixture in the layer.
[0390] For example, the alignment step can be performed by an electric field or with the aid of an alignment layer by stretching, rubbing or exposure to polarized light.
[0391] Thus, the compound of formula (A) or (B) or the dichroic dye mixture or the liquid crystal composition can be used in applications where the compound of formula (A) or (B) or the dichroic dye mixture is fixed in a polymer matrix, typically formed by a polymerizable LC material, or in applications for switchable optical devices comprising the compound of formula (A) or (B) or the dichroic dye mixture and an LC material.
[0392] In the first case, the compound of formula (A) or (B) or the dichroic dye mixture can be used as part of the light-absorbing anisotropic element for static anisotropic films, usually based on polymerizable liquid crystal materials, which have various applications. Examples are stretched polymer films, coatable polarizers, phase difference films, anti-counterfeiting markings such as in banknotes, credit cards or identity cards, or brand protection markings, etc.
[0393] A stretched polymer film is a film in which the polymers are all oriented in the same direction.
[0394] The coatable polarizer is, for example, an in-line polarizer or polarizing film for a liquid crystal display (LCD) or an organic light emitting diode (OLED).
[0395] Such films are usually formed by using polymerizable LC materials, such as LC molecules containing one or two alkyl(oxy)acrylate groups at one or both ends, such as compounds of the following formula:
[0396] Alkyl-O-[LC]-O-(CH2) n -O-CO-C(R)=CH2,
[0397] wherein [LC] represents the mesogenic part of the molecule, alkyl is, for example, an alkyl group having 1-12 carbon atoms, R is H or methyl, and n is an integer of 1-12.
[0398] Thus, the present invention relates in another aspect to an optically anisotropic film comprising a compound of formula (A) or (B) as defined herein or a dichroic dye mixture as defined herein or a liquid crystal composition as defined herein.
[0399] The present invention in a preferred aspect relates to an optically anisotropic film which is a stretched polymer film, a coatable polarizer, a phase difference film, an anti-counterfeiting label or a brand protection label.
[0400] Alternatively, the compound of formula (A) or (B) or the dichroic dye mixture or the liquid crystal composition may be used in a switchable optical device.
[0401] Therefore, the present invention relates in another aspect to a switchable optical device comprising a compound of formula (A) or (B) as defined in any aspect herein or a dichroic dye mixture as defined in any aspect herein or a liquid crystal composition as defined in any aspect herein. Preferably, the present invention relates to a switchable optical device comprising a compound of formula (A) or (B) as defined in any aspect herein or a dichroic dye mixture as defined in any aspect herein.
[0402] The switchable optical device can be, for example, a polymer dispersion (PDLC) system, a reverse PDLC system, a polymer network liquid crystal (PNLC) system, etc. The switchable optical device can also be a smart window shutter, a transmissive display or a reflective display, preferably using a black dichroic dye mixture. The switchable optical device can also be a decorative shutter, a transmissive display or a reflective display, preferably using a single dichroic dye or a color dichroic dye mixture. The color dichroic dye mixture used in the present invention is not a black dichroic dye mixture. The reflective display can be used in an electronic shelf label.
[0403] The liquid crystal composition containing the compound of formula (A) or (B) is usually present in the switchable layer of the switchable optical device. The liquid crystal composition can be present in pure form or in the form of a polymer dispersed liquid crystal layer.
[0404] Polymers suitable for dispersing the liquid-crystal mixtures according to the invention are known to the person skilled in the art and are, for example, polyacrylates, polymethacrylates and related copolymers, or polyurethanes.
[0405] Suitable structures for switchable optical devices are known in the art, such as TN (twisted nematic) switchable elements (for example described in DE 3022818 A1), STN (super twisted nematic) switchable elements (for example described in EP0260450 A1) and VA (vertically oriented) switchable elements.
[0406] Other suitable structures for switchable optical devices are liquid crystal-polymer composites such as PDLC (polymer dispersed liquid crystal) systems or reverse PDLC systems, for example as described in M. Schadt et al., Jpn. J. Appl. Phys., 34, 1995, pp. 3240-3249 or Paul S. Drzaic, Pure & Applied Chem., 68 (7), 1996, pp. 1435-1440, or PNLC (polymer network liquid crystal) systems, for example as described in J. Sun, S.-T. Wu, Polym. Phys., 52 (3), 2014, pp. 183-192.
[0407] The switchable optical device can be used in / as a window (smart window), for example in architectural glazing or skylights, in displays, switchable optical elements or mirrors with variable transmittance.
[0408] In a preferred embodiment, the smart window should be switchable from transparent to black or grey and vice versa. Therefore, dichroic dyes with different absorption bands are mixed to achieve absorption of almost the entire visible light spectrum or most of the sunlight.
[0409] Such smart windows can be used in several applications, such as buildings, furniture, cars, trains, airplanes and ships, as well as facades, skylights, glass roofs, stair slabs, glass bridges, awnings, fences, car windows and train windows, ophthalmic lenses, sunglasses, sports glasses or 3D glasses.
[0410] Therefore, the present invention relates in a preferred aspect to a switchable optical device, which is a polymer dispersed liquid crystal system, a reverse polymer dispersed liquid crystal system, a polymer network liquid crystal system, a smart window shutter, a transmissive display, a reflective display or a decorative shutter.
[0411] The compounds of formula (A) or (B) are dichroic dyes based on azo-azomethine structures. They are characterized by sufficiently high dichroic ratios and high compatibility in liquid crystal compositions, such as high solubility and good durability, especially high light resistance. They show very broad absorption spectra and high extinction, resulting in the need for smaller amounts of dichroic dyes.
[0412] Furthermore, the azo-azomethine dyes of formula (A) and (B) are characterized by high purity, high photostability and resistivity. They are easily obtained by using aldehydes as structural units which do not require azo units.
[0413] LC compositions containing the dichroic dye mixture of the present invention, preferably a black dichroic dye mixture containing another blue dichroic dye, show good durability such as high light stability.
[0414] Therefore, dichroic dyes are very suitable for the application of light-absorbing anisotropic devices and the use of smart windows.
[0415] The definitions and preferences given hereinbefore for the compounds of formula (A) or (B) apply in any combination and also apply in any combination to the other aspects of the invention.
[0416] The present invention will now be explained in more detail with reference to the following examples. These examples should not be considered limiting. Unless otherwise indicated, "%" is always weight % (wt%). Example
[0417] Examples 1-35 were prepared using the following azo precursors.
[0418] Azo Precursor I of Formula (I): prepared according to Example 6a of WO 2011 / 157614 A1.
[0419]
[0420] Azo precursor II of formula (II): prepared according to Example 6b of WO 2011 / 157614 A1
[0421]
[0422] Azo precursor IV of formula (IV): prepared according to Example 4a of WO 2011 / 157614 A1
[0423]
[0424] Azo precursor VI of formula (VI): prepared according to Example 3a of WO 2011 / 157614 A1
[0425]
[0426] Azo precursor VII of formula (VII): prepared according to Example 9a of WO 2011 / 157614 A1
[0427]
[0428] Synthesis Example 1 :Azo Precursor III
[0429] 1.1 g (5 mmol) of 4-[(E)-(4-aminophenyl)azo]benzonitrile (prepared as described in Macromol. Chem. Phys. 2007, p. 208) was dissolved in 25 ml of N-methylpyrrolidone (NMP). The solution was cooled to 5-10° C. and 1.54 g (48 mmol) of nitrosylsulfuric acid (40%) was added dropwise. The resulting tetrazo solution was stirred at 10° C. for 1 hour. 0.71 g (5 mmol) of 1-naphthylamine was dissolved in 25 ml of methanol and cooled to 5° C. and the tetrazo solution was added in one portion. The resulting mixture was stirred at 5° C. for 1 hour. After 1 hour, 1.3 ml of 1N sodium hydroxide solution was added. The resulting dark purple precipitate of formula (III) was filtered off and washed with water and methanol. Yield 1.35 g (72%).
[0430]
[0431] Synthesis Example 2 :Azo Precursor V
[0432] a) 36.0 g of 4-aminobenzonitrile (0.30 mol) was dissolved in 150 ml of methanol and 450 ml of 2N HCl was added. The yellow solution was cooled to 5°C and then 76 ml of 4N aqueous sodium nitrite solution was slowly added over 38 minutes under stirring. The resulting suspension was stirred at 5°C for 3 hours and then 36.4 g (0.30 mol) of 2,5-dimethylaniline in 250 ml of isopropanol was slowly added to a cooled (5°C) solution while 350 ml of isopropanol was added. The resulting mixture was stirred overnight at a slowly increasing temperature (5°C to room temperature (RT)). The red-purple suspension was filtered, the residue was dispersed in 800 ml of water and sodium hydroxide solution (30%) was added until the pH rose to 8-9. The mixture was filtered and the filter cake was dried (50°C / 200 mbar) to give an orange solid product of formula (Va). Yield 58 g (77%).
[0433]
[0434] b) 30.5 g (0.12 mol) of the product of step a) are dissolved in 300 ml of NMP, the resulting red solution is cooled to -2°C, 38 g of nitrosylsulfuric acid are then added at -2°C over 25 minutes and stirred for a further 90 minutes. The resulting red-orange suspension is added over 15 minutes to a cooled (5°C) solution of 17 g (0.12 mol) of 1-naphthylamine in 100 ml of NMP and 100 ml of 2N HCl. The resulting suspension is diluted by adding a further 250 ml of NMP and stirred overnight at a slowly increasing temperature (5°C to RT). 600 g of ice are added and after stirring for 1 hour the precipitate is filtered off and then washed with brine. The residue is dispersed in 1500 ml of water and the pH is adjusted to 9-9.5 with a 30% aqueous NaOH solution. The precipitate is filtered and dried to give the dark purple solid azo precursor V of formula (Vb). Yield 28 g (58%).
[0435]
[0436] Synthesis Example 3 :Azo Precursor VIII
[0437] a) 12.0 g of 4-aminocyanobenzene (0.1 mol) was dispersed in 300 ml of 1 N HCl and cooled to 5° C., then 26 ml of 4 N aqueous sodium nitrite solution was slowly added over 26 minutes while stirring. The bright yellow dispersion was stirred for 2 hours at 5° C., and excess nitrite was destroyed by adding aminosulfonic acid. The resulting solution was slowly added to a solution of 21.5 g of anilino methanesulfonate (0.1 mol) in water and 25 g of sodium bicarbonate at 5° C. while stirring for 10 minutes. The resulting orange suspension was stirred for 2 hours at 5° C., stirred for 17 hours at room temperature, and then filtered. The precipitate was dispersed in 1 L of water at 70° C., then 100 ml of 30% aqueous NaOH solution was added, while the temperature was raised to 80° C. After 30 minutes, the suspension was cooled to 40° C., filtered, the precipitate was washed with water and dried (200 mbar / 50° C.), to give an orange product of formula (VIIIa). Yield 17.1 g (77%).
[0438]
[0439] b) 10.3 g of the compound of formula (VIIIa) (46 mmol) were dissolved in 270 ml of tetrahydrofuran (THF). The orange solution was cooled to 5° C., then 10 ml of a 50% aqueous solution of tetrafluoroboric acid and 8.5 ml of tert-butyl nitrite were added (within 1 minute) and stirred at 10-15° C. for 2 hours. The resulting suspension was filtered and the purple residue was washed twice with tert-butyl methyl ether, each time using 100 ml, to give the corresponding diazo Tetrafluoroborate.
[0440] c) 12.5 g of sodium acetate trihydrate (92 mmol) and 3.7 g of m-toluidine (35 mmol) were dissolved in 150 ml of methanol and cooled to 5° C. 7.77 g (35 mmol, 1 eq) of the product of step b) were added and the resulting suspension was stirred for 3 hours at 5° C. The suspension was filtered, the residue was washed with methanol / water (1:1) and dried to give 7.6 g of a brown solid azo precursor VIII of formula (VIIIc).
[0441]
[0442] Example 1
[0443] 4.19 g (10 mmol) of azo precursor II was suspended in a mixture of 29.7 ml of n-propanol and 2.1 ml of acetic acid, and then 5.32 g of diethylaminobenzaldehyde (30 mmol) and 13.34 g of activated molecular sieves (Aldrich UOP type 8-12 mesh, ). The mixture was refluxed for 48 hours and then cooled to room temperature. The solid was filtered off and washed with 10 ml of n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give a dark red solid of formula (1) after drying. Yield 1.15 g (20%).
[0444] 1 H-NMR (400 MHz, CDCl3): δ=1.28 (t, CH3, 6H), 3.50 (q, CH2, 4H), 6.79 (d, Ar-H, 2H), 7.16 (d, Ar-H, 1H), 7.63 (m, Aryl-H, 2H), 7.74 (m, Aryl-H, 2H), 7.88 (dd, Aryl-H, 4H), 8.04 (d, Aryl-H, 1H), 8.09 (d, Aryl-H, 2H), 8.20 (m, Aryl-H, 4H), 8.45 (s, N=C H , 1H), 8.51 (d, aryl-H, 1H), 9.06 (d, aryl-H, 1H).
[0445]
[0446] Example 2
[0447] 2.21 g (5 mmol) of azo precursor II was suspended in a mixture of 15.6 ml of n-propanol and 1.1 ml of acetic acid, and then 2.82 g of 4-phenylbenzaldehyde (10 mmol) and 7.02 g of active molecular sieves ( ). The mixture was refluxed for 24 hours and then cooled to room temperature. The solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated and an orange solid of formula (2) was obtained after drying the product (50° C., 200 mbar). Yield 1.60 g (55%).
[0448] 1 H-NMR (400 MHz, CDCl3): δ = 7.21 (d, aryl-H, 1H), 7.42-7.47 (m, aryl-H, 1H), 7.53 (m, aryl-H, 2H), 7.65-7.78 (m, aryl-H, 4H), 7.83 (t, aryl-H, 4H), 8.4 (d, aryl-H, 1H), 8.10 (dd, aryl-H, 2H), 8.15-8.26 (m, aryl-H, 6H), 8.48 (d, aryl-H, 1H), 8.67 (s, C H =N, 1H), 9.08 (d, aryl-H, 1H).
[0449]
[0450] Example 3
[0451] 4.19 g (10 mmol) of azo precursor II was suspended in a mixture of 31.2 ml of n-propanol and 2.2 ml of acetic acid, and then 1.34 g of 4-cyanobenzaldehyde (10 mmol) and 14.04 g of activated molecular sieves ( ). The mixture was refluxed for 48 hours and then cooled to room temperature. The solid was filtered off and washed with n-propanol, the residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated and the product was dried at 50° C. and 200 mbar to obtain an orange solid of formula (3). Yield 3.12 g (59%).
[0452] 1 H-NMR (400 MHz, CDCl3): δ = 7.22 (d, aryl-H, 1H), 7.69 (m, aryl-H, 1H), 7.79 (m, aryl-H, 1H), 7.83-7.88 (m, aryl-H, 4H), 8.02 (d, aryl-H, 1H), 8.10 (d, aryl-H, 2H), 8.17-8.27 (m, aryl-H, 5H), 8.43 (d, aryl-H, 1H), 8.68 (s, N=C H , 1H), 9.08 (d, aryl-H, 1H).
[0453]
[0454] Example 4
[0455] 1.23 g (2.14 mmol) of azo precursor II was dissolved in 25 ml of toluene, and then 0.32 g (2.14 mmol) of 4-ethoxybenzaldehyde and 3 g of active molecular sieves ( ). The resulting mixture was refluxed under N2 for 30 hours. After cooling to room temperature, the mixture was filtered and the residue was washed with 20 ml of toluene. The filtrate was evaporated, the residue was stirred in 30 ml of methanol and stirred at 58° C. for 30 minutes. The mixture was filtered while hot and the residue was washed with 30 ml of methanol. The residue was suspended in dichloromethane to dissolve the product and filtered. The dichloromethane filtrate was evaporated to obtain the product of formula (4) after drying (80° C. / 125 mbar).
[0456] MALDI-TOF-MS (positive mode): 552.4
[0457] 1H-NMR (400 MHz, CDCl3): δ=1.51 (t, 3H, CH3), 4.18 (q, 2H, CH2), 7.06 (d, 2H, aryl-H), 7.17 (d, 1H, aryl), 7.65 (m, 1H, aryl-H), 7.76 (m, 1H, aryl-H), 7.84 (d, 2H, aryl-H), 8.02 (m, 3H, aryl-H), 8.09 (m, 2H, aryl-H), 8.17 (m, 2H, aryl-H), 8.23 (m, 2H, aryl-H), 8.46 (d, 1H, aryl-H), 8.54 (s, 1H, C H =N), 9.06 (d, 1H, aryl-H).
[0458]
[0459] Example 5
[0460] 1.23 g (2.14 mmol) of azo precursor II was dissolved in 25 ml of toluene, and then 0.32 g (2.14 mmol) of piperonal and 1 g of active molecular sieves ( ). The red mixture was refluxed under N2 for 30 hours. After cooling to room temperature, the mixture was filtered and washed with 80 ml of toluene. The filtrate was evaporated and the residue was purified by flash chromatography using heptane / ethyl acetate (5:1) as eluent to give a reddish-orange solid of formula (5) after drying (95°C / 125 mbar).
[0461] MALDI-TOF-MS (negative): 551.3
[0462] 1 H-NMR (400 MHz, CDCl3): δ=6.10 (m, 2H, OCH2), 6.97 and 7.18 (d, 1H each, aryl-H), 7.40 (m, 1H, aryl-H), 7.66 (m, 1H, aryl-H), 7.76 and 7.84 (m, 2H each, aryl-H), 8.0-8.25 (m, 7H, aryl-H), 8.46 (m, 1H, aryl-H), 8.49 (s, 1H, CH=N), 9.08 (d, 1H, aryl-H).
[0463]
[0464] Example 6
[0465] 1.50 g (5.7 mmol) of azo precursor I was dissolved in 50 ml of toluene, and then 0.38 g (2.8 mmol) of terephthalaldehyde and 3 g of active molecular sieves ( ). The resulting mixture was heated to 110° C. under N2 and maintained for 30 hours. After cooling to RT, the red mixture was filtered and the residue was washed with toluene and ethyl acetate. The residue containing the molecular sieves was stirred in dichloromethane, the mixture was filtered off and washed with dichloromethane, and the combined dichloromethane filtrates were evaporated to give a dark solid of formula (6) after drying (95° C. / 125 mbar).
[0466]
[0467] Example 7
[0468] 2.21 g (5 mmol) of azo precursor II are suspended in a mixture of 15.6 ml of n-propanol and 1.1 ml of acetic acid, and then 0.68 g of terephthalaldehyde (5 mmol) is added. The mixture is refluxed for 48 hours, cooled to RT and filtered. The precipitate is washed with n-propanol and 5 ml of THF and dried (50° C. / 200 mbar) to give an orange-red solid of formula (7). Yield 1.29 g (55%).
[0469] 1 H-NMR (400 MHz, CDCl3): δ=7.23 (d, 2H, aryl-H), 7.69 (m, 2H, aryl-H), 7.79 (m, 2H, aryl-H), 7.85 (d, 4H, aryl-H), 8.03 (d, 2H, aryl-H), 8.09 (d, 8H, aryl-H), 8.18 (d, 4H, aryl-H), 8.24-8.28 (m, 8H, aryl-H), 8.46 (d, 2H, aryl-H), 8.72 (s, 2H, aryl-H), 9.08 (d, 2H, aryl-H), 10.17 (s, 2H, CH=N).
[0470]
[0471] Example 8
[0472] 17.66 g (42 mmol) of azo precursor II was suspended in a mixture of 124.9 ml of n-propanol and 8.9 ml of acetic acid, and then 9.97 g of salicylaldehyde (80 mmol) and 56.16 g of active molecular sieves ( ). The mixture was refluxed for 24 hours, a further 4.98 g of salicylaldehyde (40 mmol) was added and then refluxed for another 24 hours. The mixture was cooled to RT, the solid was filtered off and washed with 10 ml of n-propanol. The residue was suspended in THF, the solid was filtered off and washed with THF. The filtrate was evaporated to give a dark red solid of formula (8) after drying (50° C. / 200 mbar). Yield 12.9 g (62%).
[0473] 1 H-NMR (400 MHz, CDCl3): δ=7.05 (t, aryl-H, 1H), 7.16 (d, aryl-H, 1H), 7.33 (d, aryl-H, 1H), 7.47-7.55 (m, aryl-H, 2H), 7.68-7.74 (m, aryl-H, 1H), 7.77-7.82 (m, aryl-H, 1H), 7.85 (d, aryl-H, 1H), 8.04 (d, aryl-H, 1H), 8.10 (d, aryl-H, 1H), 8.19 (d, aryl-H, 2H), 8.26 (d, aryl-H, 2H), 8.39 (d, aryl-H, 1H), 8.80 (s, N=C H , 1H), 9.10 (d, aryl-H, 1H), 13.14 (broad, OH, 1H).
[0474]
[0475] Example 9
[0476] 0.50 g (1.19 mmol) of azo precursor II was dissolved in 20 ml of dimethylformamide (DMF), and then 0.14 g (1.02 mmol) of 4-methyl-2-hydroxybenzaldehyde and 3 g of active molecular sieves ( ). The red mixture was stirred at 140° C. and N2 for 48 hours. After the molecular sieves were separated by filtration, the solvent was removed by distillation to dryness. The product was purified by flash chromatography on silica gel using heptane / ethyl acetate (4:1) as eluent to give a reddish brown powder of formula (9) after drying (95° C. / 125 mbar). Yield 0.58 g (91%). NMR spectrum showed a mixture of cis- and trans-imines.
[0477] MALDI-TOF-MS (positive): 538.4
[0478] 1H-NMR (400MHz, CDCl3): δ = 2.45 (s, 3H, Ar- CH3 ), 7.2-7.4 (m, 2H, aryl-H), 7.68-7.82 (m, 2H, aryl-H), 7.85 (d, 2H, aryl-H), 8.0-8.4 (m, 8H, aryl-H), 8.76 and 8.81 (2s, 1H, CH=N), 9.09 (m, 1H, aryl-H).
[0479]
[0480] Example 10
[0481] 0.25 g (0.6 mmol) of azo precursor II was dissolved in 15 ml of DMF, and then 0.09 g (0.6 mmol) of 2-hydroxy-3-ethoxybenzaldehyde and 1 g of active molecular sieves ( ). The red mixture was stirred at 130° C. and N2 for 4 hours. 0.09 g (0.6 mmol) of 2-hydroxy-3-ethoxybenzaldehyde was added. Stirring was continued at 130° C. for 17 hours. After the molecular sieves were separated by filtration, the solvent was removed by distillation to dryness. The product was purified by flash chromatography on silica gel using heptane / ethyl acetate (4:1) as eluent to give a dark solid of formula (10) after drying (95° C. / 125 mbar). Yield 66 mg (20%).
[0482] MALDI-TOF-MS (positive): 554.4
[0483] 1 H-NMR (400 MHz, CDCl3): δ=4.03 (s, 3H, OCH3), 7.0 (m, 1H, aryl-H), 7.12 (m, 1H, aryl-H), 7.15 (m, 1H, aryl-H), 7.38 (m, 1H, aryl-H), 7.7-7.9 (m, 4H, aryl-H), 8.0-8.3 (m, 7H, aryl-H), 8.41 (m, 1H, aryl-H), 8.82 (s, 1H, CH=N), 9.1 (m, 1H, aryl-H), 13.67 (s, 1H, OH).
[0484]
[0485] Embodiment 11
[0486] 4.98 g (10 mmol) of azo precursor II was suspended in a mixture of 35.3 ml of n-propanol and 2.5 ml of acetic acid, and then 3.51 g of 2-hydroxy-1-naphthaldehyde (20 mmol) and 15.84 g of active molecular sieves ( ). The mixture was refluxed for 17 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 0.66 g of black crystals of formula (11) after drying (50° C. / 200 mbar).
[0487] 1H-NMR (300 MHz, CDCl3): δ=7.26 ppm (d, aryl-H, 1H), 7.44 (t, aryl-H, 1H), 7.51 (d, aryl-H, 1H), 7.59-7.64 (m, aryl-H, 1H), 7.73-7.86 (m, aryl-H, 6H), 7.95 (d, aryl-H, 1H), 8.09 (d, aryl-H, 1H), 8.11 (d, aryl-H, 2H), 8.19 (m, aryl-H, 2H), 8.24 (m, aryl-H, 3H), 8.46 / 8.49 (2s, C H =N, 1H), 9.12 (m, aryl-H, 1H), 9.63 (s, OH, 1H).
[0488]
[0489] Example 12
[0490] 0.65 g (17 mmol) of azo precursor III was suspended in 20 ml of anhydrous DMF under stirring, and then 210 mg (17 mmol) of salicylaldehyde was added. The mixture was heated to 120° C. and maintained for 48 hours. Then 0.11 ml of methanesulfonic acid was added. The mixture was filtered, the filtrate was evaporated and the crude product was purified by silica gel chromatography using heptane / acetylacetate (gradient of 9:1-1:1) to obtain a dark solid of formula (12) after drying. Yield 15 mg (19%).
[0491] MALDI-TOF-MS (negative): 479.2
[0492] 1 H-NMR (400 MHz, CDCl3): δ=7.0-8.4 (m, 17H, aryl-H), 8.81 (s, 1H, CH=N), 9.1 (m, 1H, aryl-H), 13.13 (s, 1H, OH).
[0493]
[0494] Embodiment 13
[0495] 4.19 g (10 mmol) of azo precursor II was suspended in a mixture of 31.2 ml of n-propanol and 2.2 ml of acetic acid, and then 3.86 g of 4-diethylamino salicylaldehyde (20 mmol) and 14.04 g of molecular sieves ( ). The mixture was refluxed for 24 hours and then cooled to room temperature. The solid was filtered off and washed with 10 ml of n-propanol, the residue was suspended in THF to dissolve the product, and the solid was removed by filtration. The filtrate was evaporated to give a dark solid of formula (13) after drying. Yield 4.57 g (77%).
[0496] 1 H-NMR (400 MHz, CDCl3): δ=1.28 (t, CH3, 6H), 3.48 (q, CH2, 4H), 6.33 (m, aryl-H, 2H), 7.31 (s, aryl-H, 1H), 7.67 (m, aryl-H, 1H), 7.76 (m, aryl-H, 1H), 7.85 (d, aryl-H, 2H), 8.05 (d, aryl-H, 2H), 8.10 (d, aryl-H, 2H), 8.18 (m, aryl-H, 2H), 8.24 (m, aryl-H, 2H), 8.45 (d, aryl-H, 1H), 8.61 (s, CH3, 6H). H =N, 1H), 9.09 (d, aryl-H, 1H), 13.74 (s, OH, 1H).
[0497]
[0498] Embodiment 14
[0499] 2.21 g (5 mmol) of azo precursor II was suspended in a mixture of 15.6 ml of n-propanol and 1.1 ml of acetic acid, and then 1.65 g of 5-nitro-2-thiophenecarboxaldehyde (10 mmol) and 7.02 g of active molecular sieves ( ). The mixture was refluxed for 24 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give a solid product of formula (14) after drying (50°C / 200 mbar). Yield 1.85 g (66%).
[0500] 1 H-NMR (400 MHz, CDCl3): δ = 7.29 (d, 1H, aryl-H), 7.52 (d, aryl-H, 1H), 7.69-7.82 (m, aryl-H, 2H), 7.85 (d, aryl-H, 2H), 7.98-8.01 (m, aryl-H, 2H), 8.09 (d, aryl-H, 2H), 8.17-8.26 (m, aryl-H, 4H), 8.47 (d, aryl-H, 1H), 8.74 (s, C H =N, 1H), 9.06 (d, aryl-H, 1H).
[0501]
[0502] Embodiment 15
[0503] 2.21 g (5 mmol) of azo precursor II was suspended in a mixture of 15.6 ml of n-propanol and 1.1 ml of acetic acid, and then 1.12 g of 2-thiophenecarboxaldehyde (10 mmol) and 7.02 g of active molecular sieves ( ). The mixture was refluxed for 24 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give a red solid of formula (15) after drying (50°C / 200 mbar). Yield 1.92 g (75%). 1 H-NMR (400 MHz, CDCl3): δ = 7.21 (d, aryl-H, 1H), 7.23 (t, aryl-H, 1H), 7.62-7.70 (m, aryl-H, 3h), 7.74-7.79 (m, aryl-H, 1H), 7.85 (d, aryl-H, 2H), 8.01 (d, aryl-H, 2H), 8.16-8.25 (m, aryl-H, 4H), 8.48 (d, aryl-H, 1H), 8.75 (s, C H =N, 1H), 9.05 (d, aryl-H, 1H).
[0504]
[0505] Example 16
[0506] 3.99 g (10 mmol) of azo precursor IV was suspended in a mixture of 28.3 ml of n-propanol and 2.0 ml of acetic acid, and then 2.17 g of salicylaldehyde (20 mmol) and 12.70 g of activated molecular sieves ( ). The mixture was refluxed for 17 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give a dark solid of formula (16) after drying (50°C / 200 mbar). Yield 3.03 g (63%). 1H-NMR (400 MHz, CDCl3): δ=7.04 (dt, aryl-H, 1H), 7.15 (d, aryl-H, 1H), 7.33 (d, aryl-H, 1H), 7.47-7.54 (m, aryl-H, 3H), 7.68-7.82 (m, aryl-H, 2H), 8.03 (d, aryl-H, 1H), 8.13 (d, aryl-H, 1H), 8.24 (s, aryl-H, 3H), 8.37 (d, aryl-H, 1H), 8.80 (s, aryl-H, 1H), 9.08 (d, aryl-H, 1H), 13.12 (s, C H =N,1H).
[0507]
[0508] Embodiment 17
[0509] 3.99 g (10 mmol) of azo precursor IV was suspended in a mixture of 28.3 ml of n-propanol and 2.0 ml of acetic acid, and then 3.94 g of 4-diethylamino salicylaldehyde (20 mmol) and 12.70 g of active molecular sieves ( ). The mixture was refluxed for 16 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give a dark solid of formula (17) after drying (50°C / 200 mbar). Yield 3.46 g (65%).
[0510] 1 H-NMR (400 MHz, CDCl3): δ=1.27 ppm (t, CH3, 6H), 3.47 (q, CH2, 4H), 6.29-6.36 (m, aryl-H, 2H), 7.26-7.30 (m, aryl-H, 2H), 7.49 (d, aryl-H, 1H), 7.64-7.79 (m, aryl-H, 2H), 8.04 (d, aryl-H, 1H), 8.11 (d, aryl-H, 1H), 8.23 (s, aryl-H, 3H), 8.44 (dd, aryl-H, 1H), 8.59 (s, aryl-H, 1H), 9.07 (d, aryl-H, 1H), 13.74 (s, CH3, 6H). H =N,1H).
[0511]
[0512] Embodiment 18
[0513] 0.42 g (10 mmol) of azo precursor III was suspended in 20 ml of toluene under stirring. 280 mg (10 mmol) of 8-hydroxy-1,1,7,7-tetramethyljulonidine-9-carboxaldehyde and 180 mg of p-toluenesulfonic acid were added to the suspension. The reaction mixture was heated to 120° C. and stirred at this temperature for 48 hours. The reaction mixture was cooled to 20° C. The product was separated by filtration. The filtrate was evaporated to dryness under vacuum. The residue was dissolved in 20 ml of dichloromethane, and then 10 ml of heptane was added dropwise. The precipitate was filtered out to obtain a dark orange oil of formula (18).
[0514] LC-MS: 674.3
[0515]
[0516] Embodiment 19
[0517] 1.63g (2.82mmol) of azo precursor II and 0.75g (2.82mmol) of azo precursor I are suspended in 30ml of toluene, and then 0.38g (2.82mmol) of terephthalaldehyde, 0.05g of p-toluenesulfonic acid are added. The mixture is refluxed for 24 hours, and then an additional 0.20g of azo precursor II is added and refluxed for another 40 hours. The mixture is filtered and the filtrate is evaporated. The residue is dissolved in ethyl acetate, filtered and the filtrate is evaporated. The residue is dissolved in chloroform, filtered and the filtrate is evaporated again, and 1.50g (58%) of an orange solid mixture of the product mainly containing formula (19) is obtained after drying (50°C / 200 mbar).
[0518]
[0519] Embodiment 20
[0520] 4.26 g (10 mmol) of azo precursor V was suspended in a mixture of 30.1 ml of n-propanol and 2.2 ml of acetic acid, and then 2.49 g of salicylaldehyde (20 mmol) and 13.54 g of activated molecular sieves ( ). The mixture was refluxed for 16 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 0.47 g (10%) of a dark solid of formula (20) after drying (50° C. / 200 mbar).
[0521]
[0522] Embodiment 21
[0523] 4.98 g (10 mmol) of azo precursor II was suspended in a mixture of 35.3 ml of n-propanol and 2.5 ml of acetic acid, and then 2.23 g of N-methyl-2-pyrrolecarboxaldehyde (20 mmol) and 15.84 g of active molecular sieves ( ). The mixture was refluxed for 36 hours, a further 1.1 g (10 mmol) of N-methyl-2-pyrrolecarboxaldehyde was added and reflux was continued for a further 20 hours. After cooling to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 5.07 g of a dark solid of formula (21) after drying (50° C. / 200 mbar).
[0524]
[0525] Embodiment 22
[0526] 3.94 g (10 mmol) of azo precursor VI was suspended in a mixture of 27.9 ml of n-propanol and 2.0 ml of acetic acid, and then 3.94 g of 4-diethylamino salicylaldehyde (20 mmol) and 12.53 g of active molecular sieves ( ). The mixture was refluxed for 16 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 1.87 g (34%) of a dark solid of formula (22) after drying (50° C. / 200 mbar).
[0527] 1 H-NMR (300 MHz, CDCl3): δ = 1.27 (t, CH3, 6H), 2.88 (s, CH3, 3H), 3.48 (q, CH2, 4H), 6.28-6.39 (m, aryl-H, 2H), 7.27 (d, aryl-H, 1H), 7.46 (d, aryl-H, 1H), 7.64-7.69 (m, aryl-H, 1H), 7.73-7.79 (m, aryl-H, 1H), 7.90-8.04 (m, aryl-H, 4H), 8.07 (d, aryl-H, 1H), 8.10 (d, aryl-H, 1H), 8,43 (dd, aryl-H, 1H), 8.58 (s, CH=N, 1H), 13.78 (br, OH, 1H).
[0528]
[0529] Embodiment 23
[0530] 1.00 g (2 mmol) of azo precursor VII was suspended in a mixture of 7.1 ml of n-propanol and 0.5 ml of acetic acid, and then 0.5 g of salicylaldehyde (4 mmol) and 3.17 g of activated molecular sieves ( ). The mixture was refluxed for 16 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 0.48 g (50%) of a dark solid of formula (23) after drying (50° C. / 200 mbar).
[0531] 1 H-NMR (300 MHz, CDCl3): δ = 1.46 (t, CH3, 3H), 4.49 (q, CH2, 2H), 7.05 (t, aryl-H, 1H), 7.16 (d, aryl-H, 1H), 7.36 (d, aryl-H, 1H), 7.48-7.56 (m, aryl-H, 2H), 7.69-7.85 (m, aryl-H, 4 H), 8.03 (d, aryl-H, 1H), 8.12-8.17 (m, aryl-H, 4H), 8.29 (d, aryl-H, 2H), 8.40 (d, aryl-H, 1H), 8.82 (s, CH=N, 1H), 9.08-9.11 (m, aryl-H, 1H), 9.18 (d, aryl-H, 2H), 13.16 (s, OH, 1H).
[0532]
[0533] Embodiment 24
[0534] 1.00 g (2 mmol) of azo precursor VII was suspended in a mixture of 7.1 ml of n-propanol and 0.5 ml of acetic acid, and then 0.79 g of 4-diethylamino salicylaldehyde (4 mmol) and 3.17 g of activated molecular sieves ( ). The mixture was refluxed for 16 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 0.87 g (67%) of a dark solid of formula (24) after drying (50° C. / 200 mbar).
[0535] 1H-NMR (300 MHz, CDCl3): δ = 1.30 (t, CH3, 6H), 1.48 (t, CH3, 3H), 3.49 (q, CH2, 4H), 4.45 (q, CH2, 2H), 6.31 (s, aryl-H, 1H), 7.30 (t, aryl-H, 1H), 7.65-7.70 (m, aryl-H, 1H) , 7.75-7.83 (m, aryl-H, 3H), 8.02-8.17 (m, aryl-H, 4H), 8.44 (d, aryl-H, 1H), 8.59 (s, CH=N, 1H), 9.05-9.09 (m, aryl-H, 1H), 9.14-9.20 (m, aryl-H, 2H), 13.77 (br., OH, 1H).
[0536]
[0537] Embodiment 25
[0538] 4.41 g (10 mmol) of azo precursor II are suspended in a mixture of 31.2 ml of n-propanol and 2.2 ml of acetic acid, and then 1.42 g of 2,5-thiophenedicarbaldehyde (10 mmol) are added. The mixture is refluxed for 16 hours, then an additional 2.20 g (5 mmol) of azo precursor II are added and the mixture is refluxed for a further 20 hours. After cooling to room temperature, the precipitate is filtered off, washed with n-propanol and the residue is dried (50° C. / 200 mbar) to give 6.27 g of a mixture containing 25:75% of compounds of formula (25a) and (25b) (by 1 H-NMR confirmed the red crystals.
[0539]
[0540] Embodiment 26
[0541] 1.20 g (2 mmol) of azo precursor IV was suspended in a mixture of 8.5 ml of n-propanol and 0.6 ml of acetic acid, and then 0.99 g of 5-nitro-2-thiophenecarboxaldehyde (6 mmol) and 3.81 g of active molecular sieves ( ). The mixture was refluxed for 16 hours, then cooled to room temperature, the solid was filtered off and extracted with n-propanol by means of a Soxhlet extractor. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give, after drying (50° C. / 200 mbar), 0.20 g (13%) of a dark solid of formula (26).
[0542] 1H-NMR (300 MHz, CDCl3): δ = 7.52 (m, aryl-H, 2H), 7.69-7.83 (m, aryl-H, 2H), 8.00 (s, aryl-H, 1H), 8.01 (d, aryl-H, 1H), 8.13 (d, aryl-H, 1H), 8.25 (s, aryl-H, 4H), 8.47 (d, aryl-H, 1H), 8.74 (s, C H =N, 1H), 9.06 (d, aryl-H, 1H).
[0543]
[0544] Embodiment 27
[0545] 2.00 g (5 mmol) of azo precursor IV was suspended in a mixture of 14.1 ml of n-propanol and 1.0 ml of acetic acid, and then 1.34 g of 5-cyanobenzaldehyde (10 mmol) and 6.35 g of activated molecular sieves ( ). The mixture was refluxed for 16 hours and then cooled to room temperature. The solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give, after drying (50° C. / 200 mbar), 0.70 g (=29%) of a dark solid of formula (27). 1 H-NMR (300 MHz, CDCl3): δ=7.22 (d, aryl-H, 1H), 7.52 (d, aryl-H, 1H), 7.66-7.71 (m, aryl-H, 1H), 7.76-7.82 (m, aryl-H, 1H), 7.87 (d, aryl-H, 2H), 8.03 (d, aryl-H, 1H), 8.13 (d, aryl-H, 1H), 8.20 (d, aryl-H, 2H), 8.25 (s, aryl-H, 3H), 8.43 (d, aryl-H, 1H), 8.68 (s, C H =N, 1H), 9.08 (d, aryl-H, 1H).
[0546]
[0547] Embodiment 28
[0548] 0.85 g (2.5 mmol) of azo precursor VIII was suspended in a mixture of 6.3 ml of n-propanol and 0.5 ml of acetic acid, and then 0.62 g of 4-diethylamino salicylaldehyde (3.2 mmol) and 2.85 g of activated molecular sieves ( ). The mixture was refluxed for 17 hours and then cooled to room temperature. The solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 0.58 g (45%) of black crystals of formula (28) after drying (50° C. / 200 mbar).
[0549] 1 H-NMR (300 MHz, CDCl3): 1.25 (t, CH3, 6H), 2.83 (s, CH3, 3H), 3.44 (q, CH2, 4H), 6.23 (s, aryl-H, 1H), 6.30 (d, aryl-H, 1H), 7.16-7.25 (m, aryl-H, 2H), 7.41 (d, aryl-H, 1H), 7.82-7.88 (m, aryl-H, 3H), 7.99-8.08 (m, aryl-H, 4H), 8.12 (m, aryl-H, 2H), 8.52 (s, CH=N, 1H), 13.5 (br, OH, 1H).
[0550]
[0551] Embodiment 29
[0552] 1.25 g (2.55 mmol) of azo precursor II was suspended in a mixture of 8.8 ml of n-propanol and 0.6 ml of acetic acid, and then 0.56 g of benzothiazole-2-carboxaldehyde (5 mmol) and 3.96 g of active molecular sieves ( ). The mixture was refluxed for 24 hours, then cooled to room temperature, the solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 1.04 g (81%) of dark crystals of formula (29) after drying (50° C. / 200 mbar).
[0553] 1 H-NMR (300 MHz, CDCl3): δ = 7.38 (d, aryl-H, 1H), 7.54-7.64 (m, aryl-H, 2H), 7.71-7.81 (m, aryl-H, 2H), 7.85 (d, aryl-H, 2H), 8.02-8.11 (m, aryl-H, 4H), 8.17-8.27 (m, aryl-H, 5H), 8.54 (d, aryl-H, 1H), 9.00 (s, C H =N, 1H), 9.08 (d, aryl-H, 1H).
[0554]
[0555] Embodiment 30
[0556] 0.75 g (1.5 mmol) of azo precursor II was suspended in a mixture of 5.3 ml of n-propanol and 0.4 ml of acetic acid, and then 0.67 g of 9-formyl-8-hydroxyjulolidine (3 mmol) and 2.38 g of active molecular sieves ( ). The mixture is refluxed for 16 hours, then cooled to room temperature, the solid is filtered off and washed with n-propanol. The residue is suspended in THF to dissolve the product, the solid is filtered off and washed with THF. The filtrate is evaporated to give dark crystals of formula (30) after drying (50° C. / 200 mbar).
[0557] 1 H-NMR (300 MHz, CDCl3): δ = 1.93-2.08 (m, CH2, 4H), 2.68-2.78 (m, CH2, 3H), 2.85 (t, CH2, 1H), 3.27-3.34 (m, CH2, 4H), 6.87 (d, aryl-H, 1H), 7.26 (d, aryl-H, 1H), 7.66 (m, aryl-H, 1H), 7.75 (m, aryl-H, 1H), 7.84 (d, aryl-H, 2H), 8.02-8.10 (m, aryl-H, 3H), 8.15-8.24 (m, aryl-H, 4H), 8.47 (d, aryl-H, 1H), 8.53 (s, CH2 H =N, 1H), 9.07 (d, aryl-H, 1H), 9.40 (s, OH, 0.3H), 11.82 (s, OH, 0.25H), 13.39 (br., OH, 0.45H).
[0558]
[0559] Embodiment 31
[0560] 2.21 g (5 mmol) of azo precursor II was suspended in a mixture of 17.6 ml of n-propanol and 1.3 ml of acetic acid, and then 2.09 g of 2-formyl-5-phenylphenol (10 mmol) and 7.93 g of active molecular sieves ( ). The mixture was refluxed for 40 hours and then cooled to room temperature. The solid was filtered off and washed with n-propanol. The residue was suspended in THF to dissolve the product, the solid was filtered off and washed with THF. The filtrate was evaporated to give 2.24 g (75%) of a black solid of formula (31) after drying (50° C. / 200 mbar).
[0561] 1H-NMR (300 MHz, CDCl3): δ = 7.34-7.39 (m, aryl-H, 2H), 7.45-7.61 (m, aryl-H, 5H), 7.72 (m, aryl-H, 3H), 7.78-7.86 (m, aryl-H, 3H), 8.05 (d, aryl-H, 1H), 8.10 (d, aryl-H, 2H), 8.17-8.27 (m, aryl-H, 4H), 8.41 (d, aryl-H, 1H), 8.84 (s, C H =N, 1H), 9.10 (d, aryl-H, 1H), 13.25 (br., OH, 1H).
[0562]
[0563] Embodiment 32
[0564] 1.23 g (2.14 mmol) of azo precursor II was suspended in 25 ml of toluene, and then 0.44 g (2.14 mmol) of 4-hexyloxybenzaldehyde and 1.0 g of active molecular sieves ( ). The mixture was refluxed for 24 hours. The mixture was filtered and the filtrate was evaporated. The residue was dissolved in dichloromethane, filtered and the filtrate was evaporated to give an orange solid of formula (32) after drying.
[0565] LC-MS (positive): 584.1
[0566]
[0567] Embodiment 33
[0568] 1.23 g (2.14 mmol) of azo precursor II was suspended in 25 ml of toluene, and then 0.32 g (2.14 mmol) of 4-dimethylaminobenzaldehyde and 3.0 g of active molecular sieves ( ). The mixture is refluxed for 30 hours. The mixture is filtered and the filtrate is evaporated. The residue is mixed in 30 ml of methanol and stirred at 58° C. for 30 minutes. The dispersion is filtered while hot and washed with methanol. The residue is dissolved in dichloromethane, filtered and the filtrate is evaporated to obtain an orange solid of formula (33) after drying.
[0569]
[0570] Embodiment 34
[0571] 0.42 g (1.0 mmol) of azo precursor II was suspended in 20 ml of toluene, and then 0.21 g (1.0 mmol) of 4-dimethylamino-1-naphthaldehyde, 0.18 g of p-toluenesulfonic acid and 3.0 g of active molecular sieves ( ). The mixture was refluxed for 72 hours. The mixture was filtered and the filtrate was evaporated. The residue was mixed with 20 ml of a heptane-ethyl acetate mixture (8:2) and stirred for 30 minutes. The dispersion was filtered and the filtrate was evaporated to give a dark solid of formula (34) after drying.
[0572]
[0573] Embodiment 35
[0574] 0.63 g (1.5 mmol) of azo precursor II was suspended in 30 ml of toluene, and then 0.21 g (1.5 mmol) of 2-methoxybenzaldehyde and 3.0 g of activated molecular sieves ( ). The mixture is refluxed for 72 hours and filtered. The filtrate is evaporated. The residue is admixed with 30 ml of methanol and stirred at room temperature for 1 hour. The dispersion is filtered and washed with methanol to give a dark solid of formula (35) after drying (50° C. / 200 mbar).
[0575] 1 H-NMR (300 MHz, CDCl3): δ = 3.97 ppm (s, CH3, 3H), 7.05 (d, aryl-H, 1H), 7.14-7.20 (m, aryl-H, 2H), 7.55 (t, aryl-H, 1H), 7.65 (t, aryl-H, 1H), 7.75 (t, aryl-H, 1H), 7.84 ( d, aryl-H, 2H), 8.03 (d, aryl-H, 1H), 8.09 (d, aryl-H, 2H), 8.18 (d, aryl-H, 2H), 8.24 (aryl-H, 2H), 8.40 (dd, aryl-H, 1H), 8.46 (d, aryl-H, 1H), 9.07 (d, aryl-H, 1H), 9.09 (s, C H =N,1H).
[0576]
[0577] Application in LC materials
[0578] Dichroic Ratio: The dichroic ratio of the dyes was measured as a nematic liquid crystal mixture in an LC cell (Linkam Scientific Instruments, UK) made of glass plates with an anti-parallel rubbed alignment layer (polyimide) and a transparent conductive layer (ITO) connected at a distance of 5 μm in an MLC-2132 (Merck KGaA).
[0579] The indicated percentage of dye was mixed into about 100 mg of MLC-2132 and 2 ml of dichloromethane. The mixture was ultrasonically treated for 10 minutes to ensure complete dissolution. After evaporation of the solvent, the remaining mixture was placed on a hot plate ( 20-250°C, Harry Gestigkeit GmbH, Düsseldorf, Germany) to 130°C, which is above the clearing point of the liquid crystal material. The LC cell was heated to 230° C. on a 100° C. RT-PCR system (20-250° C., Harry Gestigkeit GmbH, Düsseldorf, Germany) to ensure complete crosslinking of the used binder. After cooling to 130° C. the LC cell was filled with the LC-dye mixture heated as described above and subsequently cooled to room temperature.
[0580] The filled LC cells were measured using an Agilent 8453 UV-Vis spectrophotometer with a polarizer attached. Two measurements were made, one with the polarizer parallel to the polarization of the LC cell and one with the polarizer oriented perpendicular to the polarization of the LC cell. The dichroic ratio is given by the parallel (A) of the maximum absorbance in the perpendicular state. ll ) and vertical (A ⊥ ) Absorbance ratio calculation: DR = A ll / A ⊥ The dichroic ratios are listed in Table 1.
[0581] Lightfastness For light fastness measurements, an Atlas sunlight tester (Atlas Material Testing Technology GmbH, Germany) with a UV cutoff filter was used at 450 W / m 2 The filled LC cell prepared as described above was repeatedly irradiated with a power of 40 hours. The decay of the dye extinction was measured after each 40-hour cycle. The decay duration of the dye was extrapolated or interpolated to a residual 50% extinction, indicating the irradiation duration after which the dye-LC mixture exhibited a residual 50% extinction. The decay durations are listed in Table 1. Acceptable decay times are typically 160 hours or longer.
[0582] Table 1
[0583]
[0584]
[0585] Examples 36-38
[0586] Black mixtures of dichroic dyes in the liquid crystal material MLC-2132 were prepared as described above for the single compounds, except that various amounts of the single compounds were used according to the following listing. The amounts are mentioned in % by weight.
[0587] Blue disazo dye = Example 6c, as described in WO 11 / 157614 A1
[0588] Red disazo dye = Example 10b, as described in WO 11 / 157614 A1
[0589] Yellow disazo dye = Example 31, as described in WO 11 / 157614 A1
[0590] Dichroic Dyes Comparative Example 1 Embodiment 36 Embodiment 37 Embodiment 38 Blue trisazo dye 1.7 1.4 1.6 1.6 Red disazo dye 0.2 - 0.2 - Yellow disazo dye 1.0 - - 1.0 Example 3 - 1.2 1.2 - Example 1 - 0.3 - 0.4
[0591] Figure 1-3 It is shown that the dichroic dye mixtures of the prior art (see Figure 4 ), the light fastness can be improved when a black dichroic mixture containing at least one azomethine dye of the present invention is used.
Claims
1. Compound of formula (A) in Ar 1 yes The residues of Ar 2 and Ar 3 Independently and at each occurrence, selected from Ar 4 yes The residues of X is C 1 -C 6 Haloalkyl, halogen, CN, COOR 17 ,CONR 18 R 19 or SO 2 R 20 ; Y is H, C 1 -C 12 Alkyl, OH or NH 2 Replaced and / or replaced by NR 23 , O or S interval C 1 -C 12 Alkyl, C 1 -C 12 Haloalkyl, C 7 -C 12 Aralkyl, NR 24 R 25 , halogen, CN, OH, C 1 -C 12 Alkoxy, C interrupted by O 2 -C 12 Alkoxy, C 1 -C 12 Alkylthio, COOR 26 , C 6 -C 12 Aryl, C 1 -C 12 Alkyl, C 1 -C 12 Alkoxy, C 1 -C 12 Alkylthio, CN, halogen, OH or NR 27 R 28 Substituted C 6 -C 12 Aryl, C 2 -C 10 Heteroaryl, C 1 -C 12 Alkyl, C 1 -C 12 Alkoxy, C 1 -C 12 Alkylthio, OH, halogen, CN or NR 29 R 30 Substituted C 2 -C 10 Heteroaryl, C 3 -C 18 Cycloalkyl or C 1 -C 12 Haloalkyl, halogen, CN, OH, C 1 -C 12 Alkoxy, C 1 -C 12 Alkylthio or NR 31 R 32 C substituted and / or interrupted by one or more O 3 -C 18 Cycloalkyl; Or Y and an adjacent H together form a group or a 5-7 membered heterocyclic ring containing one or two Qs, Q is NR 33 , O or S; The group or the heterocyclic ring is unsubstituted or replaced by C 1 -C 4 Alkyl substitution; R 1 It is C 1 -C 12 Alkyl, C 1 -C 12 Haloalkyl, halogen, CN, C 1 -C 12 Alkoxy or O-interrupted C 2 -C 12 Alkoxy; R 8 and R 9 Independently and at each occurrence, select from C 1 -C 4 Alkyl, C 1 -C 4 Haloalkyl, halogen, CN or C 1 -C 4 Alkoxy; R 10 Select C at each occurrence 1 -C 12 Alkyl, C 1 -C 4 Haloalkyl, C 1 -C 12 Alkoxy, OH, halogen or CN; R 17 , R 20 and R 26 Independently of each other, C 1 -C 12 Alkyl, C substituted by CN or OH 1 -C 12 Alkyl, C 1 -C 12 Haloalkyl, C 3 -C 18 Cycloalkyl, C 1 -C 12 Haloalkyl, CN, OH or halogen substituted and / or C 3 -C 12 Cycloalkyl, C 6 -C 12 Aryl, halogen, CN, OH, C 1 -C 12 Alkyl or C 1 -C 12 Haloalkyl substituted C 6 -C 12 Aryl, phenylene-C 3 -C 18 Cycloalkyl, phenylene-C substituted by halogen, CN or OH 3 -C 18 Cycloalkyl, C 3 -C 12 Cycloalkylenephenyl or C 1 -C 12 Alkyl, C 1 -C 12 C substituted with halogenated alkyl, halogen, CN or OH 3 -C 12 Cycloalkylenephenyl; R 18 , R 19 , R 24 , R 25 , R 27 , R 28 , R 29 , R 30 , R 31 or R 32 Independently of each other are H, C 1 -C 12 Alkyl, C 3 -C 14 Cycloalkyl, C 6 -C 12 Aryl, halogen, CN, OH, C 1 -C 12 Alkyl or C 1 -C 12 Haloalkyl substituted C 6 -C 12 Aryl, phenylene-C 3 -C 18 Cycloalkyl, phenylene-C substituted by halogen, CN or OH 3 -C 18 Cycloalkyl, C 3 -C 12 Cycloalkylenephenyl or C 1 -C 12 Alkyl, C 1 -C 12 C substituted with halogenated alkyl, halogen, CN or OH 3 -C 12 Cycloalkylenephenyl; or R 18 and R 19 , R 24 and R 25 , R 27 and R 28 , R 29 and R 30 or R 31 and R 32 Together for C 2 -C 12 Alkylene or replaced by O, S and / or NR 41 Interval C 2 -C 12 Alkylene; R 23 , R 33 and R 41 Independently of each other, H, C 1 -C 12 Alkyl, C 3 -C 12 Cycloalkyl, phenyl or C 1 -C 6 Alkyl, F or CN substituted phenyl; m and n are independently 0 or 1, The condition is that the sum m+n ≥ 1; and s, t, u and v are independently 0, 1 or 2.
2. A compound according to claim 1 having one of the following formulae: in Ar 1 yes The residues of Ar 4 yes The residue of 3 ,F,CN,COOR 17 ,CONR 18 R 19 or SO 2 R 20 ; Y is H, C 1 -C 12 Alkyl, OH or NH 2 Replaced and / or replaced by NR 23 or O-interval C 1 -C 12 Alkyl, CF 3 , C 7 -C 12 Aralkyl, NR 24 R 25 , F, CN, OH, C 1 -C 12 Alkoxy, C 1 -C 12 Alkylthio, COOR 26 , C 6 -C 12 Aryl, C 1 -C 12 Alkyl, C 1 -C 12 Alkoxy, C 1 -C 12 Alkylthio, CN, F, OH or NR 27 R 28 Substituted C 6 -C 12 Aryl, C 2 -C 10 Heteroaryl, C 1 -C 12 Alkyl, C 1 -C 12 Alkoxy, C 1 -C 12 Alkylthio, OH, F, CN or NR 29 R 30 Substituted C 2 -C 10 Heteroaryl, C 5 -C 18 Cycloalkyl or CF 3 , F, CN, OH, C 1 -C 12 Alkoxy, C 1 -C 12 Alkylthio or NR 31 R 32 C substituted and / or interrupted by one or more O 5 -C 18 Cycloalkyl; Or Y and an adjacent H together form a group or a 5-7 membered heterocyclic ring containing one or two Qs, Q is NR 33 , O or S; The group or the heterocyclic ring is unsubstituted or replaced by CH 3 replace; R 1 It is C 1 -C 4 Alkyl, CF 3 , F, CN or C 1 -C 4 Alkoxy; R 8 and R 9 Independently and at each occurrence is CH 3 CF 3 , F, CN or OCH 3 ; R 10 Select C at each occurrence 1 -C 8 Alkyl, CF 3 , F, C 1 -C 8 Alkoxy, OH or CN; R 17 , R 20 and R 26 Independently of each other, C 1 -C 8 Alkyl, C substituted by CN 1 -C 8 Alkyl, C 5 -C 14 Cycloalkyl, C substituted by CN or F 5 -C 14 Cycloalkyl, phenyl, F, CN, C 1 -C 8 Alkyl or CF 3 Substituted phenyl, phenylene-C 5 -C 14 Cycloalkyl, phenylene-C substituted by F or CN 5 -C 14 Cycloalkyl, C 5 -C 12 Cycloalkylenephenyl or C 1 -C 8 Alkyl, CF 3 , F or CN substituted C 5 -C 12 Cycloalkylenephenyl; R 18 , R 19 , R 24 , R 25 , R 27 , R 28 , R 29 , R 30 , R 31 and R 32 Independently of each other, H and C 1 -C 8 Alkyl, C 5 -C 14 Cycloalkyl, phenyl, C 1 -C 8 Alkyl substituted phenyl, phenylene-C 5 -C 14 Cycloalkyl, C 5 -C 12 Cycloalkylenephenyl or C 1 -C 8 Alkyl substituted C 5 -C 12 Cycloalkylenephenyl, or R 18 and R 19 , R 24 and R 25 , R 27 and R 28 , R 29 and R 30 or R 31 and R 32 Together for C 3 -C 6 Alkylene or replaced by O, S and / or NR 41 Interval C 3 -C 6 Alkylene; R 23 , R 33 and R 41 Independently of each other, H and C 1 -C 8 Alkyl, C 5 -C 6 Cycloalkyl or phenyl; m and n are independently 0 or 1, The condition is that the sum m+n ≥ 1; and s, t, u and v are independently 0, 1 or 2.
3. A compound according to claim 1 or 2, wherein Ar 1 yes The residues of Ar 4 yes The residues of X is CF 3 ,F,CN,COOR 17 ,CONR 18 R 19 or SO 2 R 20 ; Y is H, C 1 -C 8 Alkyl, CF 3 , NR 24 R 25 , F, CN, OH, C 1 -C 8 Alkoxy, C 1 -C 8 Alkylthio, COOR 26 , phenyl, C 1 -C 8 Alkyl, C 1 -C 8 Alkoxy, C 1 -C 8 Alkylthio, F, CN or NR 27 R 28 Substituted phenyl, or C 5 -C 14 Cycloalkyl; Or Y and an adjacent H together form a group or a 5-7 membered heterocyclic ring containing one or two Qs, Q is NR 33 or O; The group or the heterocyclic group is unsubstituted or replaced by CH 3 replace; R 1 CH 3 CF 3 , F or CN; R 10 Select C at each occurrence 1 -C 8 Alkyl, CF 3 , F, C 1 -C 8 Alkoxy, OH or CN; R 17 , R 20 and R 26 Independently of each other, C 1 -C 8 Alkyl, C 5 -C 14 Cycloalkyl, phenyl, C 1 -C 8 Alkyl substituted phenyl, phenylene-C 5 -C 14 Cycloalkyl or C 5 -C 12 Cycloalkylenephenyl; R 18 , R 19 , R 24 , R 25 , R 27 and R 28 Independently of each other, H and C 1 -C 8 Alkyl, C 5 -C 14 Cycloalkyl, phenyl, phenylene-C 5 -C 14 Cycloalkyl or C 5 -C 12 Cycloalkylenephenyl; or R 18 and R 19 , R 24 and R 25 or R 27 and R 28 Together for C 5 -C 6 Alkylene or O or NR 41 Interval C 3 -C 6 Alkylene; R 33 and R 41 Independently of each other, H and C 1 -C 4 Alkyl, C 5 -C 6 Cycloalkyl or phenyl; s is 0 or 1; and v is 0, 1, or 2.
4. A compound according to claim 1 or 2 having one of the following formulae: in Ar 1 yes The residues of Ar 4 yes The residues of X is CF 3 ,F,CN,COOR 17 ,CONR 18 R 19 or SO 2 R 20 ; Y is H, C 1 -C 8 Alkyl, NR 24 R 25 , F, CN, OH, C 1 -C 8 Alkoxy, C 1 -C 8 Alkylthio, COOR 26 , phenyl, C 1 -C 8 Alkyl, C 1 -C 8 Alkoxy, C 1 -C 8 Alkylthio or NR 27 R 28 Substituted phenyl, or C 5 -C 14 Cycloalkyl; Or Y and an adjacent H together form a group or a 5-6 membered heterocyclic ring containing one or two Qs, Q is NR 33 or O; The group or the heterocyclic group is unsubstituted or replaced by CH 3 replace; R 1 Yes CH 3 CF 3 , F or CN; R 8 and R 9 Independently and at each occurrence is CH 3 ; R 10 Select C at each occurrence 1 -C 8 Alkyl, CF 3 , F, C 1 -C 8 Alkoxy, OH or CN; R 17 , R 20 and R 26 Independently of each other, C 1 -C 5 Alkyl, C 6 -C 12 Cycloalkyl, phenyl, C 1 -C 5 Alkyl substituted phenyl, phenylene-C 6 -C 12 Cycloalkyl or C 6 -C 12 Cycloalkylenephenyl; R 18 , R 19 , R 24 , R 25 , R 27 and R 28 Independently of each other, H and C 1 -C 8 Alkyl, C 5 -C 14 Cycloalkyl, phenyl, phenylene-C 6 -C 12 Cycloalkyl or C 6 -C 12 Cycloalkylenephenyl; or R 18 and R 19 , R 24 and R 25 or R 27 and R 28 Together for C 5 -C 6 Alkylene or O or NR 41 Interval C 3 -C 6 Alkylene; R 33 and R 41 Independently of each other, H and C 1 -C 4 Alkyl, C 5 -C 6 Cycloalkyl or phenyl; t and v are independently 0, 1 or 2; and s and u are independently 0 or 1.
5. A compound according to claim 1 or 2, wherein Ar 1 yes The residues of Ar 4 yes The residues of X is CF 3 , F, CN or COOR 17 ; R 10 It is C 1 -C 7 Alkyl, CF 3 , F, Cl, Br, C 1 -C 6 Alkoxy, OH or CN; Y is H, C 1 -C 7 Alkyl, OH or NH 2 Substituted C 1 -C 7 Alkyl, NR 24 R 25 , F, CN, OH, C 1 -C 6 Alkoxy, COOR 26 , phenyl, C 1 -C 7 Alkyl, C 1 -C 6 Alkoxy or NR 27 R 28 Substituted phenyl, or C 5 -C 6 Cycloalkyl; Or Y and an adjacent H together form a group or a 5-6 membered heterocyclic ring containing one or two Qs, Q is NR 33 or O; The group or the heterocyclic ring is unsubstituted or replaced by CH 3 replace; R 17 and R 26 Independently of each other, C 1 -C 5 Alkyl, C 6 -C 12 Cycloalkyl, phenyl, C 1 -C 5 Alkyl substituted phenyl, phenylene-C 6 -C 12 Cycloalkyl or C 6 -C 12 Cycloalkylenephenyl; R 24 , R 25 , R 27 and R 28 Independently H or C 1 -C 5 alkyl, or R 24 and R 25 or R 27 and R 28 Together for C 5 -C 6 Alkylene or O or NR 41 Interval C 5 -C 6 Alkylene; R 33 and R 41 Independently H or C 1 -C 4 Alkyl; and v is 0, 1, or 2.
6. A process for preparing a compound of formula (A) as defined in any one of claims 1 to 5, by condensing an amino-substituted azo compound of formula (AA) with an aldehyde of formula (AB):
7. A dichroic dye mixture comprising one or more compounds of formula (A) as defined in any one of claims 1 to 5 and, optionally, one or more further dichroic dyes.
8. A dichroic dye mixture according to claim 7, said mixture being a black mixture.
9. A liquid crystal composition comprising a liquid crystal material and at least one compound of formula (A) as defined in any one of claims 1 to 5 or a dichroic dye mixture as defined in claim 7 or 8.
10. A light-absorbing anisotropic element comprising one or more compounds of formula (A) as defined in any one of claims 1 to 5 or a dichroic dye mixture as defined in claim 7 or 8 or a liquid crystal composition as defined in claim 9.
11. A switchable optical device comprising one or more compounds of formula (A) as defined in any one of claims 1 to 5 or a dichroic dye mixture as defined in claim 7 or 8 or a liquid crystal composition as defined in claim 9.
12. The switchable optical device according to claim 11, wherein the switchable optical device is a polymer dispersed liquid crystal system, a reverse polymer dispersed liquid crystal system, a polymer network liquid crystal system, a smart window shutter, a transmissive display, a reflective display or a decorative shutter.
13. An optically anisotropic film comprising one or more compounds of formula (A) as defined in any one of claims 1 to 5 or a dichroic dye mixture as defined in claim 7 or 8 or a liquid crystal composition as defined in claim 9.
14. The optically anisotropic film according to claim 13, which is a stretched polymer film, a coatable polarizer, a phase difference film, an anti-counterfeiting label or a brand protection label.
15. Use of a compound of formula (A) as defined in any one of claims 1 to 5 or a dichroic dye mixture as defined in claim 7 or 8 or a liquid crystal composition as defined in claim 9 in a light-absorbing anisotropic element as a component of a switchable optical device or a component of an optically anisotropic film.
